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Abstract
Obesity is a chronic metabolic disorder associated with increased risk of
cardiovascular disease. Evidence suggests that chronic intermittent fasting
improves cardiometabolic health and reduces arterial blood pressure.
However, the mechanisms underlying the reductions in blood pressure and
improved cardiovascular health observed from chronic fasting studies remain
unclear. The autonomic nervous system has a central role in the regulation of
blood pressure and is essential for cardiovascular homeostasis. We
conducted a study to investigate how acute fasting influences autonomic
control of blood pressure at rest and during stress. Twenty-five young,
healthy, normal weight, normotensive participants were tested twice, once in
the fed state (3 hours postprandial) and again in the fasted state (24 hours
postprandial). Aim 1 of the study was to determine the influence of an acute
fast on hemodynamics, peripheral neural activity, and cardiovascular control
at rest. To fulfill this aim we measured 24-hour ambulatory blood pressure for
both conditions leading up to an autonomic function test. During the
autonomic function test, we controlled breathing at 0.25 Hz and measured
blood pressure, heart rate, muscle sympathetic nerve activity, and forearm
blood flow for 10 minutes. Fasting reduced overall ambulatory blood pressure
and heart rate compared to the fed condition. From the autonomic test we
measured enhanced vagal modulation of the heart through 1) increased R-R
interval and heart rate variability measured via spectral analysis; 2) Increased
spontaneous (rest) and dynamic (Valsalva Maneuver) cardiovagal baroreflex
sensitivity indicating enhanced reflexive vagal activation. Fasting did not alter
peripheral sympathetic activity or blood pressure during the autonomic test.
However, forearm vascular resistance and stroke volume were increased
during the fasting condition. Aim 2 investigated if fasting influenced
cardiovascular and neural reactivity to a mental stressor (5 min mental
arithmetic). Fasting did not augment neural or cardiovascular reactivity to a
13

mental stress challenge. Aim 3 investigated if fasting reduced orthostatic
tolerance to intense lower body negative pressure (LBNP). LBNP was applied
in a stepwise manner until participants became presyncopal. Fasting reduced
the duration of negative pressure participants could tolerate before
presyncope occurred. The reduced tolerance to central hypovolemia seems
to have been caused by an impaired ability to increase peripheral resistance
as measured from the forearm. This dissertation provides novel insight into
how systemic energy balance influences autonomic regulation of blood
pressure. Specifically, that fasting reduces 24-hour ambulatory blood
pressure, increases vagal modulation of the heart, and enhances cardiovagal
baroreflex sensitivity.
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1 INTRODUCTION
1.1 The Problem of Plenty
In the United States, overeating, inactivity, and obesity have emerged as
serious public health challenges that reduce life expectancy (Peeters et al.,
2003). The problem has only gotten worse as we progress through the 21st
century. Caloric intake in the United states has increased 22% in women and
7% in men between 1971 and 2000 (Wright, Kennedy-Stephenson, Wang,
McDowell, & Johnson, 2004). The prevalence of obesity in the U.S.
population increased from ~31% to ~42% from 2000 to 2018 (Hales, Carroll,
Fryar, & Ogden, 2020). Accessible countermeasures are needed to abate the
rise in obesity and improve life expectancy and health. It is well established
that physical activity enhances cardiometabolic health and increases life
expectancy in humans in a dose dependent manner (Mandsager et al., 2018;
Moore et al., 2012; Reimers, Knapp, & Reimers, 2012). However, only ~23%
of American adults over 18 years old engage in the recommended amount of
physical activity (Blackwell & Clarke, 2018). Recently, caloric restriction and
intermittent fasting have been proposed as countermeasures to improve
cardiometabolic health and potentially increase life expectancy.

1.2 An Evolutionary Perspective
In developed societies such as the United States hyperpalatable foods
are abundant and accessible to a majority of the population. Undoubtedly, this
abundance of food has allowed for sustained population growth throughout
the 21st century. However, regular intake of calorically dense food represents
a significant divergence from homo sapiens evolutionary history. Early human
societies that subsisted on hunting and gathering evolved in environments
where they intermittently experienced periods of little to no caloric intake
(Crittenden & Schnorr, 2017). In these societies caloric intake was
15

opportunistic, and periods of fasting were not uncommon. In order to survive
these environments our ancestors had to constantly make the metabolic shift
from glucose utilization and fat storage (lipogenesis) during times of plenty, to
fat breakdown (lipolysis) and ketone utilization for energy when food was
scarce. The switch to lipolysis and the mobilization of fatty acids for energy
production only occurs once glycogen stores in the liver are depleted.
Depending on energy expenditure and liver glycogen stores, the switch to
lipolysis occurs approximately 12 to 36 hours after caloric cessation and is
characterized by the production of ketones (β-hydroxybutyrate) from
triglycerides (Merimee, Misbin, & Pulkkinen, 1978). In the fasted condition,
ketone bodies provide a major source of energy. However, in the United
States it is common for individuals to consume 3 meals a day plus snacks.
This constant energy intake keeps ketone levels low, as there is a near
continuous infusion of glucose for energy. People who adhere to the 3 meals
a day eating pattern never make the metabolic switch to the production and
utilization of ketones for energy unless they engage in strenuous exercise.
We as a species are physiologically well suited for periods of caloric
restriction and complete caloric cessation. Sections 1.3 and 1.4 will briefly
cover the emerging evidence supporting the potential health benefits of
chronic caloric restriction and intermittent fasting.

1.3 Caloric Restriction, Cardiometabolic Health, and
Lifespan
Caloric restriction has been reported to significantly increase the
lifespan and delay the onset of age-related disease. In lower order
eukaryotes, such as yeast and worms, caloric restriction extends their
lifespan by 3 fold (Fontana, Partridge, & Longo, 2010). Caloric restriction is
also reported to extend the lifespan of higher order eukaryotes like flies (by 2
fold) and mice (by 30-50%) (Fontana et al., 2010). There may also be benefits
16

to the lifespan of primates who consume a calorie restricted diet. In 1989 a
longitudinal study commenced in rhesus monkeys investigating caloric
restriction and lifespan. By 2013, 63% (24/38) of the control animals died of
age-related causes, compared to only 26% (10/38) of the animals in the
caloric restricted group (Colman et al., 2014). The rhesus monkey study is still
active. The most recent report in 2017 reported that six calorie restricted
monkeys had lived beyond the age of 40 years old, which was previously
thought to be maximal lifespan for the species (Mattison et al., 2017). The
degree of caloric restriction that confers maximal benefits to the lifespan is
unknown. However, the evidence suggests that lower caloric intake improves
lifespan in animals.
To date, there is no direct evidence to support that caloric restriction
increases the lifespan of humans. The most prominent caloric restriction
study conducted in humans is the Comprehensive Assessment of Long-term
Effects of Reducing Intake of Energy trial (CALERIE). The CALERIE trial was
conducted in 218 healthy non-obese men and women and prescribed a diet
that had 25% less calories than needed to maintain energy balance over a 2year period. While the diet prescription was 25% below energy needs, actual
adherence in the caloric restriction group averaged out to 12% over the 2year period. As expected, participants in the caloric restriction group lost
about 10.4% of their body weight, 71% of which was fat (Kraus et al., 2019).
The study showed improvements in cardiometabolic health greater than those
conferred by the concordant weight loss. The caloric restriction group
consistently had lower low-density lipoprotein (LDL) and serum triglycerides
(TG) concentrations, which was accompanied by elevated high-density
lipoprotein (HDL) concentrations. The caloric restriction group also reported
lower systolic, diastolic, and mean arterial pressure. Insulin sensitivity was
improved and fasting glucose was lower in the caloric restriction group.
Lastly, high sensitivity C-reactive protein (hs-CRP), a measure of low-grade
17

chronic inflammation was significantly reduced at the 2 year time point (Kraus
et al., 2019). Caloric restriction of just 12% on average in this population
improved multiple indicators of cardiometabolic health and reduced risk
factors for cardiovascular disease. Additional support for the hypothesis that
caloric restriction has cardiovascular benefits comes from observational
studies. 18 individuals who reported self-imposed caloric restriction for 3-15
years exhibited similar cardiovascular benefits as the participants in the
CALERIE trail. The observational study reported that in the caloric restricted
group blood pressure, carotid artery intima media thickness, LDL, TG were
lower and HDL were higher than the age-matched comparison group
(Fontana, Meyer, Klein, & Holloszy, 2004). The CALERIE trial and the
observational study provide evidence that caloric restriction may be beneficial
for cardiovascular health. However, the metabolic switch from preferential
glucose utilization to ketone bodies for energy does not occur during caloric
restriction as energy intake does not cease. Without exercise, fasting is
required for the metabolic switch to occur and for ketone production to
commence. This may be an important metabolic distinction between caloric
restriction and fasting because the ketone β-hydroxybutyrate has been
reported to inhibit sympathetic nerve activity in cell cultures and rat models
(Kimura et al., 2011). Intermittent fasting requires the complete cessation of
energy intake for a specific time period resulting in the production of ketone
bodies. Section 1.4 will discuss the beneficial association between chronic
intermittent fasting and cardiovascular health.

1.4 Chronic Intermittent Fasting and Cardiovascular
Health
Intermittent fasting is a rapidly growing dieting concept popular with
individuals seeking to lose weight. The most popular intermittent fasting
regimens are alternate day fasting, 5:2 intermittent fasting (fasting 2 days out
of the week), and time restricted feeding (Anton et al., 2018). 5:2 and
18

alternate day fasting commonly involve fasting for an entire 24 hours. Studies
have demonstrated that intermittent fasting can promote weight loss and
increase fat oxidation in obese and non-obese populations (Heilbronn, Smith,
Martin, Anton, & Ravussin, 2005; Varady et al., 2013) Additionally,
intermittent fasting has been utilized by weight lifters to successfully reduce
body fat mass while maintaining muscle mass (Moro et al., 2016). Separate
from weight loss fasting may convey other health benefits. Two observational
studies have reported that populations who periodically fast as infrequently as
once a month have reduced prevalence of diabetes and coronary artery
disease (Horne et al., 2012). When adjusted for age, sex, BMI, hypertension,
hyperlipidemia, smoking, and family history, the meta-analysis suggested that
odds of diabetes were 43% lower and coronary artery disease 42% lower in
the infrequent fasters (Horne et al., 2008; Horne et al., 2012) suggesting that
even an acute periodic fast may have beneficial cardiovascular and metabolic
outcomes. The cardiovascular benefits of fasting have primarily been
investigated in chronic fasting models.
In rats, intermittent fasting increases heart rate variability and reduces
blood pressure and heart rate (Mager et al., 2006). Reductions in blood
pressure measured in the rats was attributed to enhanced parasympathetic
activation at the heart. The ability for fasting to reduce blood pressure has
also been observed in humans. A recent review reported that chronic
intermittent fasting is beneficial for lowering blood pressure in obese and nonobese individuals (Malinowski et al., 2019). One month of alternate day
fasting effectively lowers blood pressure and heart rate, suggesting that
chronic fasting may enhance parasympathetic activity (Stekovic et al., 2019).
A drop in blood pressure has also been measured in men observing
Ramadan fasting (Samad et al., 2015). However, the influence of fasting on
the autonomic nervous system and the mechanism responsible for the
observed reduction in blood pressure remains unclear. The autonomic
19

nervous system is intimately linked to cardiovascular health. Remarkably, few
studies have investigated how an acute fast influences autonomic balance in
humans (section 2.5) or how fasting affects autonomic cardiovascular control
of blood pressure. Therefore, the purpose of this research study is to
identify how an acute 24-hour fast influences autonomic cardiovascular
and neurovascular control of arterial pressure at rest and during stress.

1.5 Summary
We are far removed from the eating and activity patterns of our early
ancestors. Nevertheless, humans are metabolically well equipped to
compensate for periods of complete cessation in energy intake. Humans are
capable of making the metabolic switch from glucose for energy production to
ketones through the breakdown of fat. It is well established that reducing
caloric intake through restriction or fasting will result in weight loss. Current
evidence suggests that fasting could have cardiovascular benefits separate
from weight loss. However, knowledge on how the autonomic nervous system
influences cardiovascular control of blood pressure during periods of fasting is
limited. This dissertation will contribute new knowledge to the field of
autonomic physiology by investigating how acute fasting influences
cardiovascular and neurovascular control of blood pressure at rest and during
stress.
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2 LITERATURE REVIEW
2.1 Obesity
2.1.1 State of the Disease
Obesity in adults is most commonly defined as having a body mass
index greater than or equal to 30 kg/m2. According to a 2020 report from the
Centers for Disease Control and Prevention in 2017-2018, 42.4%(~138
million people) of the population in the United States is considered obese
(Hales et al., 2020). These data show an approximate 12% increase in the
overall prevalence of obesity since the year 2000. Obesity is a chronic
metabolic disorder associated with increased risk of cardiovascular disease,
stroke, type 2 diabetes, and overall mortality (Poirier et al., 2006). In 2008
alone, medical costs associated with obesity were estimated to be 147 billion
dollars (Finkelstein, Trogdon, Cohen, & Dietz, 2009). Obesity affects some
groups disproportionally. Non-Hispanic Black adults and Hispanic adults have
the highest prevalence of obesity at 49.6% and 42.2% (Ogden et al., 2017).
The association between obesity, income, and educational level is complex
and varies by sex, race, and ethnicity. Obesity prevalence is lower among
college graduates for White men and women, Black women, and Hispanic
women but not for Black and Hispanic men. In general, women with a higher
income are less likely to be obese. However, there is no difference in obesity
prevalence between the lowest and highest income groups in men (Ogden et
al., 2017). Obesity is often considered to be a result of either excessive
energy intake and/or of insufficient energy expenditure. This is known as
energy imbalance and will be further explored in the next section.
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2.1.1.1 Energy Balance Theory
The first law of thermodynamics states that internal energy of a system
equals the net heat transfer into the system minus the net work done by the
system. This can be explained by the following equation
Equation 1: 1st Law of Thermodynamics

∆𝑼 = 𝑸 − 𝑾
ΔU= change in internal energy of the system
Q = is the sum of all heat transfer into and out of the system
W = the net work done on or by the system
Applied to human metabolism, Q is heat transfer out of the body and
lost to the environment (meaning Q is always negative and relatively
constant). W is the sum of work done by the body (energy expenditure) and
also work done on the body in the form of food (energy intake). There are
three uses for energy in human metabolism; heat transfer, doing work, or
storage in the form of fat. The first law of thermodynamics assures that body
weight cannot change if over time energy intake and energy expenditure are
equal. Energy balance has played a central role in the study of human
obesity. Weight gain must be caused by a positive energy balance just as
weight loss must be caused by a negative energy balance. The equations
below summarize this concept.
Equation 2: Energy Balance
Energy Intake > Energy Expenditure = Weight Gain (positive energy balance; +U)
Energy Intake < Energy Expenditure = Weight loss (negative energy balance; -U)
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Multiple studies have attempted to ascertain if excessive energy intake
or insufficient energy expenditure is the primary driver for human obesity.
Those who claim excessive energy intake as the cause of obesity have
reported that highly palatable energy dense foods lead to accidental excess
energy consumption (Prentice & Jebb, 2003). Others who claim insufficient
energy expenditure as the cause of obesity have reported that over the last
50 years daily energy expenditure has declined by more than 100 calories
(Church et al., 2011). It is likely that both excessive energy intake and
insufficient energy expenditure contribute to the increase in the prevalence of
obesity in the United States. Bariatric surgery is currently the most effective
treatment for obesity and all procedures effectively decrease energy intake or
energy absorption to result in weight loss. (Waseem, Mogensen, Lautz, &
Robinson, 2007). However, bariatric surgery is an invasive and expensive
intervention. Other lifestyle weight loss strategies such as diet and exercise
should always be the first options for promoting weight loss.
The first law of thermodynamics cannot be violated in regard to the
onset, maintenance, or reversal of obesity. However, obesity is an extremely
complex disease sensitive to genomic, metabolic, and environmental
influences. The autonomic nervous system has been proposed to have an
integrated regulatory role in maintaining constant energy storage and
expenditure. Studies in both animals and humans have reported that the
autonomic nervous system responds to changes in systemic energy balance.
The following sections will describe the autonomic nervous system and how it
responds to acute energy intake and energy deprivation.
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2.2 Autonomic Nervous System
2.2.1 The Autonomic Nervous System
2.2.1.1 A Brief History and Organization of the Autonomic Nervous System
The first identification and description of the Peripheral Vegetative
Nervous System (i.e. Autonomic Nervous System; ANS) was first made by
Galen in 150 A.D by dissecting pigs. However, Galen’s physiological ideas
were heavily influenced by humoral theory and he thus believed that the
nerves he identified were used to transfer animal spirits to muscle and organs
in what he described as sympathetic action (Ackerknecht, 1974). The term
Autonomic Nervous System (ANS) would not be coined until 1898 by John
Newport Langley. Langley is recognized for his work concerning the
anatomical organization of the ANS. Langley is also credited with
distinguishing the sympathetic and parasympathetic branches of the ANS.
The basis for the separate distinction of the sympathetic and parasympathetic
branches of the ANS was the recognition that multiple organ systems are
under the opposing influences of two sets of nerves. The importance of the
balance between the sympathetic and parasympathetic branches of the
autonomic nervous system would become evident in the work of Claude
Bernard. Bernard’s work identified numerous autonomic effector targets, such
as the influence of the vagus nerve on heart rate, the glycemic function of the
liver, and the link between blood flow and temperature regulation. Bernard
also famously coined the phrase milieu interior or internal environment stating
that “The constancy of the internal environment is the condition for free and
independent life.”(Wehrwein, Orer, & Barman, 2011) The concept that
maintenance of a constant internal environment was revolutionary at the time
and is a fundamental tenet in the discipline of human physiology. Walter B.
Canon expanded upon Bernard’s work and highlighted the central role of the
ANS in maintaining a constant internal environment. Cannon coined the term
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homeostasis to described factors that maintain internal stability, stating “If a
state remains steady it does so because any tendency towards change is
automatically met by increased effectiveness of the factor which resist the
change.” Cannon went on to describe that thirst, hypoglycemic reaction, and
thermogenic functions all become more intense as the disturbance to
homeostasis is more pronounced (Walter B Cannon, 1929). These corrective
factors are necessary for the maintenance of constant internal state and
governed by the branches of the ANS.
2.2.1.2 The Sympathetic Branch
The sympathetic nervous system (SNS) is a division of the autonomic
nervous system whose preganglionic neurons are located between the first
thoracic and first few lumbar spinal segments (C8-L2). Sympathetic
preganglionic neurons are relatively short compared to the receiving
postganglionic neurons that proceed to the effector organ. Sympathetic
preganglionic neurons release acetylcholine (ACH) to their receiving nerve
terminals that then transmit the nerve action potential to release
norepinephrine (NE) at the target effector organ. Sympathetic postganglionic
neurons mainly terminate on smooth muscle, but also project into the thoracic
cavity to innervate the heart, bronchi, and visceral targets such as the
gastrointestinal tract, urinary bladder, and kidneys. Most blood vessels are
exclusively innervated by the sympathetic postganglionic neurons making the
sympathetic nervous system the primary regulator of peripheral vascular
resistance and the governor of blood flow throughout the body.
The unique characteristic of the SNS to control blood flow and thus
direct necessary resources to organs and muscle makes it the primary
system called upon when responding to danger and stress. This responsibility
of the sympathetic nervous system to respond to danger earned it the
designation the “fight or flight response.” The SNS prepares the body to fight
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or flee by 1) increasing heart rate and contractility thus cardiac output by
direct stimulation; 2) increasing blood flow to active muscles while
concurrently decreasing blood flow to metabolically inactive organs not
needed for motor function such as the gastrointestinal tract and kidneys; 3)
bronchodilation in the lungs to facilitate greater ventilation; 4) enhancing
utilization of glycogen stores to increase blood glucose; and 5) mobilizing
epinephrine from the adrenal glands into the blood stream to enhance
glycogenolysis and reduce muscle fatigue (Walter Bradford Cannon, 1922).
The sum of these mechanisms allows for the best possible conditions for
maximal physical effort to escape or neutralize the threat.
Two classes of adrenergic receptors are primarily responsible for
mediating the sympathetic cascade of the fight or flight response, alpha (α1,
α2) and beta (β1, β2). The agonists for alpha and beta receptors are
epinephrine, released mostly from adrenal medulla and norepinephrine
released predominantly from sympathetic nerves. Briefly, α1 receptors are
expressed on vascular smooth muscle and facilitate vasoconstriction through
the binding of epinephrine or norepinephrine. The α1 receptor has high affinity
to both epinephrine and norepinephrine. In low concentrations epinephrine
paradoxically causes vasodilation until a threshold saturation is reached and
vasoconstriction is facilitated. The α2 receptor are primarily localized on
presynaptic nerve terminals and act to inhibit norepinephrine release to
attenuate excitatory transmission. The β1 receptor are present in the heart
and have a greater affinity for epinephrine and increase heart rate and
contractility when activated. Lastly, β2 receptors are present in the smooth
muscle of the respiratory tract and have a high affinity for epinephrine that
induces relaxation or dilation (Wehrwein et al., 2011; William Tank & Lee
Wong, 2011).
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The circulating levels of epinephrine in conjunction with circulating and
directly released norepinephrine increase during stress and physical activity
(Zouhal, Jacob, Delamarche, & Gratas-Delamarche, 2008). Epinephrine and
norepinephrine are the primary agonists of the sympathetic nervous system
responsible for resting vascular tone and mediating rapid mobilization of
resources for physical activity. However, many autonomic effector organs are
influenced by the parasympathetic nervous system. The sympathetic and
parasympathetic nervous system are anatomically and functionally distinct
and control autonomic effector organs synergistically, antagonistically, and
independently.
2.2.1.3 The Parasympathetic Branch
The parasympathetic nervous system (PNS) is a division of the
autonomic nervous system whose preganglionic neurons project from cranial
nerves III, VII, IX, X and the sacral region of the spinal cord (S2-S4). A
divergent characteristic of the PNS is that all preganglionic and postganglionic
neurons of the parasympathetic nervous system release acetylcholine (ACh).
Unlike the sympathetic nervous system, the preganglionic neurons of the
parasympathetic nervous system are quite long and synapse with their
respective postganglionic neurons close to or embedded in their effector
organs. Parasympathetic fibers innervate lacrimal, oral, and nasal glands as
well as the gastrointestinal tract, rectum, kidneys and bladder. However, The
majority of parasympathetic fibers (75%) are located in cranial nerve X or the
vagus nerve (McCorry, 2007). The vagus nerve is central to autonomic
physiology because of its powerful direct influence on the sinoatrial node and
atrioventricular nodes of the heart.
ACh released from the vagus nerve binds to muscarinic receptors (M2)
on the sinoatrial node of the heart and effectively slow heart rate (Brodde,
Bruck, Leineweber, & Seyfarth, 2001). The sinoatrial node is the predominant
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pacemaker of the heart and is under the constant influence of the vagus
nerve. Without the influence of the vagus nerve the sinoatrial node would fire
at its intrinsic rate of >100 beats per minute (Shaffer, McCraty, & Zerr, 2014).
However, the heart is innervated by both sympathetic and parasympathetic
nerves. If both divisions of the ANS innervate the heart, why is heart rate
under the dominant control of the PNS? Simply put, parasympathetic nerves
exert their effects faster, with a vagal impulse reaching the SA node in less
than a second allowing for beat-to-beat modification. Cardiac sympathetic
nerves can take upward of 5 seconds to exert their influence (Nunan,
Sandercock, & Brodie, 2010). Therefore, a single vagal impulse triggers an
immediate response within the cardiac cycle and its affect is eliminated after
one or two cardiac cycles, due to rapid action of acetylcholinesterase which
breaks down ACh (Shaffer et al., 2014; Wehrwein et al., 2011). This is a
foundational concept in heart rate variability and with be expounded upon in
section 2.2.2.1.
ACh acts on two primary receptor types, nicotinic (NN) and muscarinic
(M1, M2, M3) receptors. Transmission of signals in autonomic ganglia are
primarily facilitated by nicotinic (NN) receptors which should not to be
confused with the nicotinic receptors (NM) that facilitate skeletal muscle
contraction. The only muscarinic receptors found in the autonomic synapses
of the PNS are M1, M2, and M3. M1 receptors are found in autonomic ganglia
while M2 and M3 are concentrated on PNS target organs. M2 receptors are
highly concentrated on the heart and are responsible for enabling vagal
influence over heart rate (SA node), contractility (atrial muscle), and
conduction velocity (AV node & His-Purkinje system) (Brodde et al., 2001;
Wehrwein et al., 2011). M3 receptors are associated with exocrine glands
influenced by the PNS such as pancreas β cells responsible for insulin
secretion.
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The summation of the influences of the PNS is why it is commonly
referred to as the “rest and digest system.” The SNS and PNS work in
tandem to maintain homeostasis via widespread innervation of glands,
smooth muscles, and the heart. Frequently, the PNS and SNA are thought of
conceptually in stark dichotomy. However, the PNS and SNS work in
harmony as part of an integrated regulatory system and neither works in
isolation. Section 2.2.2 will discuss how balance between these two systems
is measured and interpreted.

2.2.2 Techniques Used to Access Autonomic Balance in
Humans
2.2.2.1 Heart Rate Variability
The heart is not a metronome. Each cardiac cycle is deliberately and
meticulously controlled by the autonomic nervous system to ensure adequate
perfusion of organs critical to sustain life. Heart rate variability (HRV) is the
term used to describe changes in the time interval between consecutive
cardiac cycles at the R-wave of the electrocardiogram (ECG) or contraction of
Figure 1: ECG and R-R Interval Example
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the ventricles this can be seen in figure 1. All HRV assessments are
calculated from the time interval from R wave to adjacent R wave, known as
the R-R interval. The time interval between R waves is influenced by multiple
factors including autonomic neural activity, blood pressure, and respirations
(W. H. Cooke et al., 1998; Hirsch & Bishop, 1981). The influence of
respiration on R-R interval can be seen in figure 1. The most used methods
for assessing HRV are time-domain analyses and frequency domain analyses
(power spectral density).
2.2.2.1.1 Time Domain Analysis of Heart Rate Variability
To calculate time-domain HRV in a continuous ECG, each R wave is
detected and the time between each R wave is measured in a given time
period. The time between each R wave of the QRS complex is commonly
referred to as the normal-to-normal (NN) interval in time domain analysis. The
most commonly used measured derived from the NN interval differences
include standard deviation of the NN intervals (SDNN, unit: ms), square root
of the mean squared differences of the NN intervals (RMSSD, unit: ms), and
the percentage of successive NN intervals that differ by more than 50 ms
(PNN50, unit: %) (Electrophysiology, 1996). All these assessments measure
respiratory frequency variations between cardiac cycles. It is necessary that
when comparing these measurements of heart rate variability, the duration of
recordings is the same.
Interpreting time domain analysis of heart rate variability is relatively
straight forward. In general, and increase in SDNN, RMSSD, and PNN50%
indicate greater vagal activity at the level of the heart when comparing shortterm recordings. Time domain analysis of HRV is also valuable for cardiac
and mortality risk stratification. Over a 24-hour period SDNN is good cardiac
risk stratification tool in the acute phase of myocardial infarction (Casolo et
al., 1992). Short term ECG recordings indicate that low heart rate variability
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(SDNN) is associated with risk of death in middle-aged and elderly men
(Dekker et al., 1997). Additionally, one study found that a pNN50 <3% is
strongly associated with occurrence of a future coronary event in patients
admitted to a coronary care unit (Manfrini, Pizzi, Trerè, Fontana, & Bugiardini,
2003). After clinical stabilization 56% of patients with a pNN50 <3% had a
subsequent coronary event (Manfrini et al., 2003). These studies indicate that
reductions in time-domain measurements of heart rate variability are strong
predictors of deleterious health outcomes.
2.2.2.1.2 Frequency Domain Analysis of Heart Rate Variability
Frequency domain analysis of HRV requires the same initial steps of
time domain analysis of HRV. R waves of a continuous ECG are identified,
and the R-R time intervals are measured and plotted over time. A fast Fourier
transform (FFT) is performed on the R-R intervals data at a selected time
point. The FFT creates a power spectrum that provides information on how
variance (power) distributes over frequency. This process yields two
physiologically relevant frequency bands, the low frequency band (LF; 0.04 –
0.15 Hz) and the high frequency band (HF; 0.15 – 0.40 Hz). The HF band
reflects parasympathetic activity at the level of the heart (Hayano et al.,
1991).The physiological relevance of the LF band, traditionally associated
with sympathetic activity, has been questioned. The ability of the LF band to
reflect sympathetic activity is dubious because there is significant vagal
contribution to power density in the LF band (Eckberg, 1997). Evidence for
vagal contribution to the LF power comes largely from autonomic blockade
studies. High dosage atropine administration blocks sinoatrial responses to
acetylcholine released from the vagus nerve (Epstein et al., 1990). When
atropine is administered HF power is abolished and LF power is severely
reduced (Pomeranz et al., 1985). Thus, the reductions of LF power via
atropine administration reveals the significant vagal contribution to LF power
density. Moreover, the low frequency component of heart rate variability does
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not correlate with cardiac norepinephrine spillover, the gold standard index of
cardiac sympathetic outflow (Moak, 2007). In summary, cardiac vagal activity
is the primary contributor to the HF band and heavily influences power density
at the LF band. The LF component of heart rate variability does not reflect
cardiac sympathetic activity. The significant contribution of vagal activity to
the HF band makes HF power density a powerful reflection of vagal
modulation (parasympathetic activity) at the heart.
Spectral analysis of heart rate variability is a useful tool in evaluating
autonomic function. Similar to time domain measurements of HRV frequency
domain analysis can be used for disease risk stratification. Multiple
cardiovascular diseases exhibit a decrease in HF power and/or an increase in
LF power, such as myocardial infarction (Lombardi et al., 1996) and
hypertension (Piccirillo, Munizzi, Fimognari, & Marigliano, 1996). In sepsis
patients a reduction in LF band power below 18 ms2 is associated with
development of multiple organ dysfunction syndrome and a 64% mortality
rate (Pontet et al., 2003). Similarly, in chronic heart failure patients’
diminishment of LF band power below 11 ms2 is an independent predictor of
sudden death (Rovere et al., 2003). Both sepsis and chronic heart failure are
associated with extreme sympathetic overactivity so why does the diminishing
of LF band power act as a predictor for deleterious health outcomes?
Reduced LF power during diseases associated with sympathoexcitation may
be due to an impaired baroreflex, reduced responsiveness of the SA node, or
vagal withdrawal (Rovere et al., 2003). Nevertheless, while the usefulness of
the LF band for evaluating autonomic balance is dubious it is useful as a risk
stratification tool.
While power density is typically expressed in absolute values of power
(ms2) LF and HF can also be quantified in normalized units. Normalization is
done by dividing the LF or HF power by the total power of the spectrum and
32

multiplying by 100 (Malliani, Pagani, Lombardi, & Cerutti, 1991). Total
spectral power varies greatly between individuals. Reporting normalized units
emphasizes the balance between the LF and HF power bands relative to total
power for better interindividual comparison. Lastly, it should be noted that
cardiovascular rhythms and respirations are intimately linked through
respiratory sinus arrythmia (RSA). Variations in heart rate are synchronized
with respirations, by which the intervals between R waves on an ECG are
shortened during inspiration and prolonged during expiration. Since RSA’s
initial description and recording it has been further explored and understood
to be the modulation of the cardiac vagal efferent activity through respiratory
central drive (Shykoff, Naqvi, Menon, & Slutsky, 1991). The influence of
breathing on autonomic neural outflow make breathing a potential
confounding factor in human autonomic testing (W.H. Cooke, 1998).
Controlled (or paced) breathing ≥0.2 Hertz has been advised as a means to
increase the reproducibility and stability of heart rate variability measurements
during short-term autonomic testing (T. E. Brown, Beightol, Koh, & Eckberg,
1993; W. H. Cooke et al., 1998; Pitzalis et al., 1996).
2.2.2.2 Blood Pressure
Blood pressure is the force exerted by the blood against any unit area
of the arterial vessel wall. When blood pressure is recorded two numbers are
typically reported, systolic pressure (mmHg) which is arterial pressure when
the ventricles are contracting, and diastolic pressure (mmHg) which is arterial
pressure when the ventricles are refilling. Blood pressure should be recorded
at the level of the heart, therefore non-invasive measurements are recorded
at the upper arm.
Blood pressure is a fundamental variable of the cardiovascular system,
and short-term regulation is driven by the autonomic nervous system.
Maintaining blood pressure chronically within normotensive ranges (Systolic:
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<120 mmHg; Diastolic: <80 mmHg) is one of the homeostatic responsibilities
of both the ANS and the kidney. Adequate perfusion pressure is necessary to
maintain consciousness and avoid syncope and potential injury from falling
(Hainsworth, 2004). Conversely, chronically elevated blood pressure is a
primary contributor to cardiovascular disease and potentially organ damage.
Therefore, highly integrative responses are necessary for the control of blood
pressure. Autonomic control of blood pressure with be discussed in detail in
section 2.2.3. This section will cover non-invasive beat-to-beat and
ambulatory blood pressure recordings.
2.2.2.2.1 Noninvasive Beat-to-beat Arterial Pressure
Noninvasive continuous measurement of arterial pressure from the
finger was first introduced in the 1980’s (Imholz, Wieling, van Montfrans, &
Wesseling, 1998). Since its introduction noninvasive finger arterial pressure
has been extensively validated as a reliable method to track changes in blood
pressure (Imholz et al., 1998; Truijen, van Lieshout, Wesselink, & Westerhof,
2012). When calibrated to brachial blood pressure noninvasive finger arterial
pressure are comparable to invasively measured intraarterial brachial
pressures (Guelen et al., 2008).
Continuous measurement of arterial pressure allows for accurate
evaluation of the pressor response to stressful stimuli such as mental stress,
cold pressor test, and isometric exercise. Additionally, beat-to-beat blood
pressure measurements are essential for measuring hemodynamic
responses to the Valsalva maneuver and orthostatic stressors such as lower
body negative pressure (van Wijnen et al., 2017). When paired with ECG,
continuous arterial pressure can be used to assess spontaneous and
dynamic cardiovagal baroreflex sensitivity (described in section 2.2.3.1.).
Using the Modelflow method, beat-to-beat arterial pressure can be used to
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estimate stroke volume and cardiac output (Langewouters, Wesseling, &
Goedhard, 1984).
In conclusion, continuous blood pressure is a valuable and reliable
measurement for the assessment of pressor response, orthostatic
intolerance, and baroreflex sensitivity. However, this technique has
limitations. Continuous blood pressure recordings are often short-term and
done in a controlled laboratory setting with participants mostly stationary. Due
to these limitations continuous blood pressure recordings fail to capture the
circadian rhythm or blood pressure during normal living. The deployment of
ambulatory blood pressure devices has allowed for a more holistic look of
blood pressure over a 24 period.
2.2.2.2.2 Ambulatory Blood Pressure
Ambulatory blood pressure (ABPM) allows for the recording of multiple
blood pressure readings several times an hour across a 24-hour period.
Recording blood pressure over a 24-hour period gives ABPM the unique
ability to group blood pressure measurements into time windows of wake and
sleep recordings and render a 24-hour mean. ABPM can also be used to
evaluate the morning surge and nighttime dipping patterns of blood pressure.
Given these advantages, ABPM has become a valuable tool for the diagnosis
and management of hypertension and the prediction of cardiovascular
disease (Krakoff, 2013).
ABPM is the best measurement methodology for assessing nighttime
blood pressure dipping when paired with sleep diaries or actigraphy
measurement (Dolan et al., 2005). Measurement of nocturnal blood pressure
dipping is an increasingly important prognostic parameter for cardiovascular
morbidity and mortality. Ambulatory recordings also allow for the ruling out of
white-coat hypertension as blood pressure recordings are taken outside the
laboratory during the subject’s normal life. White-coat hypertension is a
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phenomenon wherein individuals show elevated blood pressure in clinical, or
laboratory settings. White-coat hypertension can occur in approximately 15 to
30 percent of subjects (Franklin, Thijs, Hansen, O’Brien, & Staessen, 2013).
Despite the advantages of ABPM, it also has limitations. A successful ABPM
recording requires at least 20 valid wake measurements and 7 valid sleep
measurements which can be difficult to obtain in some participants (O’Brien,
Parati, & Stergiou, 2013). ABPM monitoring can cause potential discomfort
during nighttime periods that disrupt sleep. Due to the potential for sleep
disruption, it is important to pair ABPM measurements with an objective sleep
measurement such as actigraphy, to accurately assess sleep time for
nighttime dipping calculation. Additionally, ABPM monitoring does not account
for body position at the time of measurement (seated, supine, etc.)
In conclusion, ABPM allows for the measurement of 24-hour blood
pressure and assessment of circadian driven blood pressure activity such as
nocturnal dipping and morning surge. ABPM allows for a more holistic
assessment of blood pressure compared to short-term beat-to-beat
recordings and allows for the ruling out of white-coat hypertension. In the
future ABPM may allow for the timing of hypertension medications and
lifestyle interventions to the endogenous circadian rhythm of blood pressure.
2.2.2.3 Microneurography
Microneurography is a technique used to directly record multifiber
postganglionic nerve impulses in human subjects. The microelectrode used
for the technique is made from tungsten and is inserted through the skin into
the accessible peripheral nerve. Microneurography is commonly performed in
peripheral nerves such as the peroneal neve of the leg and/or the ulnar,
median, or radial nerves of the arm. The technique was first developed by
Vallbo and Hagbarth at Academic Hospital in Uppsala, Sweden in 1966
(Vallbo, Hagbarth, & Wallin, 2004). Vallbo and Hagbarth effectively developed
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the technique to measure both efferent and afferent muscle and skin neural
activity. Muscle sympathetic nerve activity can be quantified by bursts per
minute (burst frequency) and/or by burst per 100 cardiac cycles (burst
incidence). Both burst frequency and burst incidence give insight into neural
control of the vasculature. Section 2.2.2.3.1 will expound upon the
measurement of efferent muscle sympathetic nerve activity.
2.2.2.3.1 Description, Measurements, and Reliability
Efferent postganglionic nerve activity that innervates muscle vascular
beds is a stable and reproducible measurement at baseline within individuals
(Fonkoue & Carter, 2015; Grassi et al., 1997; G Sundlof & Wallin, 1977).
Muscle sympathetic nerve activity (MSNA) is characterized by strong intraindividual reproducibility and large inter-individual variability (Fagius & Wallin,
1993). The cause for the interindividual variability of MSNA is unknown, but a
genetic component may influence MSNA as identical twins have similar basal
MSNA (B G Wallin, Kunimoto, & Sellgren, 1993). At rest, MSNA is highly
correlated with both cardiac and renal norepinephrine spillover (B. Wallin,
Thompson, Jennings, & Esler, 1996; B.G. Wallin et al., 1992) The relationship
between MSNA and norepinephrine spillover does not stand during
measurements taken during stressful stimuli, such as mental stress or
isometric handgrip (B.G. Wallin et al., 1992).
The relationship between transient rises in blood pressure and
quiescence in MSNA was first reported by Wallin (G. Sundlof & Wallin, 1978).
Wallin also observed that stimulation of the carotid sinus produced a clear
inhibition of MSNA (B. G. Wallin, Sundlöf, & Delius, 1975). Later, the arterial
baroreceptors dominance over MSNA would be proven in an elegant study by
Allyn Marks group. Upon the infusion of phenylephrine, arterial pressure
sharply increases inducing a baroreflex mediated reduction in MSNA
(Sanders, Ferguson, & Mark, 1988). Baroreflex inhibition of MSNA has been
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observed when humans consume other drugs that exhibit a pressor response
such as nicotine (Gonzalez & Cooke, 2021; Grassi et al., 1994). The
observation of baroreflex mediated inhibition of MSNA is the foundation for
the development of sympathetic baroreflex analyses.
MSNA is a major contributor in the creation and control of peripheral
vascular resistance in humans. Nonetheless, there is a paradoxical lack of
correlation between MSNA and arterial pressure (Skarphedinsson, Elam,
Jungersten, & Wallin, 1997; G. Sundlof & Wallin, 1978), meaning young
individuals whose blood pressure fall in the normotensive range can have
widely varying basal MSNA. Not until middle age (~40 years) does a
relationship between resting blood pressure and MSNA develop (Michael J.
Joyner, Charkoudian, & Wallin, 2010; Narkiewicz et al., 2005). There does
exist a negative relationship between MSNA and cardiac output in men, with
higher MSNA being associated with lower cardiac output (Michael J. Joyner
et al., 2010). Furthermore, in normotensive young men there is a positive
relationship between total peripheral resistance and MSNA; there is no
relationship in women (Emma C Hart et al., 2009). Lastly, greater waist
circumference and fat mass are strongly correlated with an increase in MSNA
in men (Jones, Davy, Alexander, & Seals, 1997).
Another persistent characteristic of MSNA is that it tends to increase
with age. These age-related changes in MSNA also differ between the sexes.
MSNA in men and women are similar at age 20. MSNA and women will then
decrease until about age 30. From age 30 on MSNA in both women and men
increase, with women having significantly lower activity until age 50 (Keir et
al., 2020). After age 50, average activity converges again between men and
women. Additionally, in both men and women younger than age of 40 no
relationship exists between baseline mean arterial pressure and MSNA.
However, after the age of 40 a positive relationship emerges in both sexes
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between baseline MSNA and mean arterial pressure (Narkiewicz et al., 2005).
In women, resting MSNA is also influenced by menstrual phase. Resting
MSNA has been reported to be higher during the mid-luteal phase of the
menstrual cycle compared to the earlier follicular phase (Minson, Halliwill,
Young, & Joyner, 2000). However, this finding was not replicated by Carter &
Lawrence who found similar resting MSNA during the mid-luteal and early
follicular phases of the menstrual cycle (Carter & Lawrence, 2007). A later
study explained the inconstancies by investigating to what degree sex steroid
surges contributed to resting MSNA (Carter, Fu, Minson, & Joyner, 2013).
Specifically, it was reported that the magnitude of estradiol increase during
the mid-luteal phase was significantly correlated with decreases in resting
MSNA (Carter, Fu, Minson, & Joyner, 2013). Hormonal contraceptives are
used by ~80% of women in the United States during their lifetime. Studies
have reported that women on oral contraceptives have higher resting blood
pressure but no change in resting MSNA when compared to normal
menstruating women (Harvey et al., 2015). Women on contraceptives also do
not have significant differences in resting MSNA during the low hormone
phase (placebo period) and high hormone phase (17-20 days after start of
estrogen-progestin pills) (Minson et al., 2000). However, it is important to note
that blood pressure, sympathetic baroreflex sensitivity, and cardiovagal
baroreflex sensitivity are all greater during the low hormone phase of
contraceptive use (Minson et al., 2000). Indicating that oral contraceptive use
can modify the mechanisms by which blood pressure is regulated in women.

2.2.3 Autonomic Control of Blood Pressure and Blood Flow
The autonomic nervous system plays a central role in the maintenance
of mean arterial pressure and cardiovascular homeostasis. An intact and
responsive ANS is paramount in the maintenance of perfusion pressure
during postural changes, food consumption, exercise, and hemorrhage.
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Concurrently, the ANS must be able to respond to sharp increases in blood
pressure to prevent serious cardiovascular complications such as stroke,
myocardial infarction, organ hyperperfusion injury and blood vessel rupture.
The ANS relies on feedback from the mechanoreceptors of the baroreflex to
regulate arterial pressure. The ANS uses feedback from the baroreflex to
regulate mean arterial pressure by altering either cardiac output and/or
peripheral resistance. Cardiac output is influenced by both heart rate and
stroke volume. The creation of vessel resistance is best described by
Poiseuille’s law (Equation 5). The radius of the vessel, which is influenced by
the sympathetic nervous system, has the greatest contribution to the creation
of peripheral resistance. The relationship between cardiac output and vessel
resistance describes mean arterial pressure.
Poiseuille’s law can also be used to understand how pressure and
resistance influence blood flow. The equation clearly shows the influence of
vessel radius on flow rate, explaining how the ANS influences both local
blood flow and mean arterial pressure through its control of the heart and
vessel radius in the periphery. The next section will focus on the negative
feedback loop of the baroreflex and how it is assessed. Additionally, the next
section will also contain a brief description of venous occlusion
plethysmography and how the technique estimates blood flow.
Equation 3: Determinants of Mean Arterial Pressure
𝑀𝐴𝑃 = 𝐶𝑎𝑟𝑑𝑖𝑎𝑐 𝑂𝑢𝑡𝑝𝑢𝑡 𝑋 𝑇𝑜𝑡𝑎𝑙 𝑃𝑒𝑟𝑖𝑝ℎ𝑒𝑎𝑟𝑙 𝑅𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒
Equation 4: Cardiac Output
𝐶𝑎𝑟𝑑𝑖𝑎𝑐 𝑂𝑢𝑡𝑝𝑢𝑡 = 𝑆𝑡𝑟𝑜𝑘𝑒 𝑉𝑜𝑙𝑢𝑚𝑒 𝑋 𝐻𝑒𝑎𝑟𝑡 𝑅𝑎𝑡𝑒
Equation 5: Determinants to Resistance to Flow (Poiseuille's Equation)
𝑉𝑒𝑠𝑠𝑒𝑙 𝑅𝑒𝑠𝑖𝑡𝑎𝑛𝑐𝑒 =

8(𝑣𝑖𝑠𝑐𝑜𝑠𝑖𝑡𝑦 𝑜𝑓 𝑓𝑙𝑢𝑖𝑑)(𝑙𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑣𝑒𝑠𝑠𝑒𝑙)
𝜋(𝑟𝑎𝑑𝑖𝑢𝑠 𝑜𝑓 𝑣𝑒𝑠𝑠𝑒𝑙)4
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Equation 6: Determinants of Flow Rate (Poiseuille's Equation)
𝜋(𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑠)(𝑅𝑎𝑑𝑖𝑢𝑠 𝑜𝑓 𝑉𝑒𝑠𝑠𝑒𝑙)4
𝐹𝑙𝑜𝑤 𝑅𝑎𝑡𝑒 =
8(𝑉𝑖𝑠𝑐𝑜𝑠𝑖𝑡𝑦 𝑜𝑓 𝐹𝑙𝑢𝑖𝑑)(𝐿𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑉𝑒𝑠𝑠𝑒𝑙)

2.2.3.1 Baroreflex Sensitivity
The primary mechanoreceptors of the baroreflex negative feedback
loop are located in the aortic arch and the carotid sinuses. The baroreflex is
the fastest mechanism to regulate acute changes in blood pressure through
both fast vagal action at the heart and slower sympathetic action in peripheral
vessels (de Boer, Karemaker, & Strackee, 1985). In other words, if blood
pressure is perturbed, sympathetically mediated changes in peripheral
resistance and sympatho-vagal modulation of heart rate and contractility
(stroke volume) work together to adjust cardiac output and maintain blood
pressure homeostasis. The ability of the baroreflex to appropriately sense
acute changes in blood pressure and respond appropriately by activating or
inhibiting the branches of the autonomic nervous system is called baroreflex
sensitivity. Impairment of the baroreflex sensitivity is associated with multiple
disease conditions such as myocardial infarction (Farrell et al., 1992), heart
failure (Mortara et al., 1997), and even type II diabetes (Kück et al., 2020).
Additionally, impaired baroreflex sensitivity is an independent prognostic
value in predicting cardiac mortality (Rovere et al., 2001). Aerobic exercise
has been reported to improve baroreflex sensitivity in healthy individuals and
improve survival after a myocardial infarction (La Rovere, Bersano, Gnemmi,
Specchia, & Schwartz, 2002; Monahan et al., 2000). Aerobic exercise has
also been reported to reverse the age associated decline in baroreflex
sensitivity (Monahan et al., 2000). Section 2.2.3.2 will discuss the hearts beatto-beat control of arterial pressure known as cardiovagal baroreflex
sensitivity.
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2.2.3.2 Cardiovagal Baroreflex Sensitivity
Cardiovagal baroreflex sensitivity (cvBRS) is described as the slope of
the relationship between the R-R interval and systolic blood pressure during
acute changes in arterial blood pressure. cvBRS contributes to the beat-tobeat control of arterial blood pressure and is an indicator of cardiac autonomic
regulation (Parlow, Viale, Annat, Hughson, & Quintin, 1995). In particular, the
sequence method of cvBRS is a good indicator of fast vagal regulation of the
heart because the parameters for the technique are usually shorter than six
beats (Silva, Dias, da Silva, Salgado, & Fazan, 2019). That cvBRS is primarly
regulated by vagal modulation has been proven through atropine infusion
which eliminates the baroreflex slope (Parlow et al., 1995). Spontaneous
baroreflex function can be assessed at rest and during forced dynamic
changes in blood pressure. At rest, cvBRS can be assessed as blood
pressure and heart rate naturally oscillate in response to respiratory rate and
Mayer waves, which have a ~10 second (0.1 Hz) rhythm (deBoer, Karemaker,
& Strackee, 1987). Assessment of the baroreflex can also be done by
perturbing blood pressure. This will be discussed in section 2.3.1 with the
Valsalva maneuver.
2.2.3.3 Venous Occlusion Plethysmography and Blood Flow
Venous occlusion plethysmography (VOP) is a minimally invasive,
relatively simple, and effective technique for assessing vascular function of
the limbs. As the name implies it requires occlusion of the veins by inflating a
cuff located proximal to the measurement site above venous pressure, but
below diastolic arterial pressure. Therefore, Inflation pressure of the cuff
prevents venous blood from leaving the limb but does not inhibit arterial blood
from entering. When taking measurements in the forearm, it is standard
practice to exclude hand circulation by inflating a secondary cuff above
arterial pressure throughout the measurement. This results in a linear
increase in limb volume over time. Changes in limb volume are then
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measured by a plethysmograph (Whitney, 1953). Measurements are made
successively, with upper cuff inflated for a 7 second recording, and then
deflates for 7 seconds to allow for venous emptying. At rest, approximately
70% of forearm blood flow is through skeletal muscle and the rest is through
skin blood vessels (Cooper, Edholm, & Mottram, 1955). VOP provides a
estimate of blood flow rate to the part of forearm enclosed by the two cuffs.
Blood flow rate depends on arterial pressure and vessel resistance
(Equation 6). Due to this relationship vascular resistance in the limb can be
estimated by taking mean arterial pressure and dividing by blood flow rate.
Equation 7: Forearm Vascular Resistance Equation
𝐹𝑜𝑟𝑒𝑎𝑟𝑚 𝑉𝑎𝑠𝑐𝑢𝑙𝑎𝑟 𝑅𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒 =

𝑀𝑒𝑎𝑛 𝐴𝑟𝑡𝑒𝑟𝑖𝑎𝑙 𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒
𝐹𝑜𝑟𝑎𝑟𝑚 𝐵𝑙𝑜𝑜𝑑 𝐹𝑙𝑜𝑤

This technique does have serious limitations. The forearm vascular resistance
equation assumes laminar flow of a Newtonian fluid, driven at a constant
pressure, through a fixed resistance (Benjamin et al., 1995). However, Blood
is not a Newtonian fluid, that can have turbulent flow, driven by a pulsatile
pressure through a distensible vessel. Therefore, calculated resistance
should be interpreted with caution.
2.2.3.4 Sex Differences in Blood Pressure Regulation
There are multiple clinically relevant sex-related differences in blood
pressure regulation between men and women. First, young men have a
higher prevalence of hypertension and in general have higher blood pressure
than women (Burt et al., 1995; Wiinberg et al., 1995). This trend continues
until age 70 and then the prevalence of hypertension in women surpasses
men. Second, young women are at higher risk of orthostatic intolerance (Ali et
al., 2000). These sex related differences in blood pressure regulation are
influenced by the sex steroids testosterone, estrogen and progesterone.
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In premenopausal eumenorrheic women the menstrual cycle is
characterized by 4 phases; menstruation, follicular phase, ovulation, and the
luteal phase. In general, studies that investigate sex difference in blood
pressure regulation divide the menstrual cycle into 2 phases, the early
follicular and mid-luteal phase. The early follicular (2-5 days after
menstruation) is commonly used among autonomic studies because it is
characterized by low estradiol and low progesterone levels. The mid-luteal (8
to 10 days after luteinizing hormone surge) serves as a good comparison time
point in the menstrual cycle because it is characterized by high estradiol and
high progesterone. Occasionally studies will include the late follicular phase
(10-14 days after menstruation) to isolate the influence of progesterone
because late follicular is characterized by low estradiol and high
progesterone. These phases are important in understanding sex differences
in blood pressure regulation because they can alter baroreflex sensitivity.
Sympathetic baroreflex sensitivity is greater in the mid-luteal phase but
cardiovagal baroreflex is not affected (Minson et al., 2000). There is no
reported difference between vascular transduction of muscle sympathetic
activity between the two phases (Minson et al., 2000). Resting MSNA is
elevated in the mid-luteal phase, but this does not translate to increases in
blood pressure (Minson et al., 2000). Later, studies demonstrated that the
increase in MSNA observed in the mid-luteal phases is related to the ratio
and concentration of the sex steroid estradiol and progesterone. Specifically,
increases in estradiol are associated with sympathoinhibition and
progesterone with sympathoexcitation (Carter et al., 2013). Another important
distinction between young men and women is that men have a positive
relationship between peripheral resistance and MSNA and women do not
(Emma C Hart et al., 2009). The lack of a relationship between peripheral
resistance and MSNA appears to be due to a reduced vasoconstrictive
response to norepinephrine in young women. However, when β-adrenergic
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receptors (vasodilate in response to norepinephrine) are blocked and
norepinephrine is infused, women exhibit vasoconstriction similar to men
(Emma C. Hart et al., 2011). Suggesting that in young women α-adrenergic
vasoconstriction may be countered by β-adrenergic vasodilation in the
periphery (Emma C. Hart et al., 2011). β-adrenergic vasodilation in the
periphery would account for the lack of relationship between MSNA and
peripheral resistance, and could contribute to the increase in orthostatic
intolerance in young women. Lastly, approximately 80% of women in the
United States will use hormonal contraceptives during their lifetime. Hormonal
contraceptives are reported to increase mean arterial pressure, but the
mechanism is unclear as MSNA does not change (Harvey et al., 2015)
Further Investigation into how sex influences blood pressure regulation is an
important and necessary field of study.

2.3 Autonomic Function Tests
As mentioned previously the autonomic nervous system has a central
role in the maintenance of homeostasis. The purpose of an autonomic
functions test is to perturb homeostasis through a physical and/or
psychological stress and measure the response. Commonly, cardiovascular
and neurovascular measures are used to quantify the autonomic response to
the test.

2.3.1 The Valsalva Maneuver
The cardiovascular and neurovascular response to the Valsalva
maneuver provides reliable and reproducible information regarding the
integrity of the baroreflex loop. The Valsalva maneuver requires a human
subject to forcefully exhale air through a mouthpiece while blocking airflow
through their nose for 15 seconds at a pressure of 40 mmHg. The Valsalva
maneuver increases intrathoracic pressure and thus impedes venous return
to the heart. This results in a fall in blood pressure that begins to rise as heart
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rate and peripheral resistance increase (Phase II). When the intrathoracic
pressure is released, venous return is restored, and cardiac output is
significantly increased. The increased cardiac output is forced into elevated
peripheral resistance causing blood pressure to rapidly rise (Phase IV). The
rise in blood pressure is blunted by a reduction in heart rate allowing for blood
pressure to stabilize. The Valsalva maneuver is a reliable and reproducible
tool to assess the arterial baroreflex sensitivity to hypotensive (Phase II) and
hypertensive (Phase IV) stimuli (displayed in figure 2) (Palamarchuk, Ives,
Hachinski, & Kimpinski, 2014).
Figure 2: Representative Valsalva Maneuver
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IV
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2.3.2 Mental Stress
Throughout human evolution the sympathetic nervous system played a
critical role in helping our ancestors survive physical threats. In the modern
world, physical threats are usually limited. However, the evolutionarily
conserved sympathetic nervous system does not discriminate between real
threats and perceived threats. Psychological stress can be induced through a
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speech task (Trier social stress test), attention task (Stroop test), and mental
arithmetic (rapid serial subtraction) (Carter & Goldstein, 2015). Mental
arithmetic induces sympathetically mediated increases in heart rate, blood
pressure, skin sympathetic nerve activity, and also causes variable muscle
sympathetic activation in humans (Carter, Kupiers, & Ray, 2005; Muller,
Sauder, & Ray, 2013). The cardiovascular and neurovascular responses to
mental stress are reproducible across laboratory sessions separated by at
least 1 month (Fonkoue & Carter, 2015). Individuals who exhibit an
exaggerated hemodynamic response to mental stress may be at heightened
risk for the development of hypertension (Chida & Steptoe, 2010). Modern
societies have mostly eliminated the need to activate the sympathetic nervous
system to survive physical threats. However, managing acute hemodynamic
reactivity to mental stress remains an important target in the prevention and
treatment of cardiovascular disease.

2.3.3 Lower Body Negative Pressure
Homo Sapiens being upright bipeds with their brains located above their
heart have a unique gravitational problem. A majority of our blood volume
(70%) is located below the level of the heart (Rowell, 1993). Gravity and the
location of the heart create the problem of venous return in upright humans.
Fortunately, we have many solutions to the problem of being a terrestrial
biped. A change in posture stimulates the otolithic organs initiating the
vestibulosympathetic reflex. The vestibulosympathetic reflex can evoke
sympathetic nerve firing to increase vascular resistance before blood
pressure changes are detected by the baroreflex (Yates, Bolton, & Macefield,
2014). The respiratory pump creates negative intrathoracic pressure that
assists in venous return. Meanwhile, large leg muscles contract and move
blood from the veins in the legs back towards the heart, known as the muscle
pump (Rowell, 1993). The muscle pump in the legs is effective due to oneway valves in the veins. The one-way valves in the veins prevent the backflow
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of blood after muscle contraction displaces volume towards the heart.
Additionally, rapid and precise control of the heart and adjustments in arterial
vascular resistance are constantly fine-tuning perfusion pressure.
Lower body negative pressure (LBNP) induces a shift in blood volume
from the central circulation of the upper body to the peripheral veins of the
lower body. When performed in the supine position LBNP does not stimulate
the otolith organs and renders the muscle pump ineffective as no significant
leg contractions occur. At high pressures, LBNP results in central
hypovolemia which unloads the arterial and cardiopulmonary baroreflexes.
The result of LBNP induced hypovolemia is dramatic cardiovascular and
neurovascular compensation to maintain arterial pressure and cerebral
perfusion (W. H. Cooke, K. L. Ryan, & V. A. Convertino, 2004). Without the
assistance of the muscle pump for venous return the maintenance of
perfusion pressure falls to the sympathetic nervous system. Sympathetic
activation maintains perfusion pressure by facilitating the creation of
peripheral resistance and enhancing cardiac output. The central hypovolemia
induced by LBNP is immediately reversed upon release of pressure. This
feature of LBNP makes it a valuable non-invasive method for investigating
sympathetic compensation to hypovolemia and orthostatic stress. LBNP is a
particularly useful tool for investigating physiological responses to simulated
hemorrhage (W. H. Cooke et al., 2004).

2.4 The Influence of Energy Intake on Autonomic
Balance
The sympathetic nervous system has a fundamental role in energy
expenditure, weight stabilization, and heat production in mammals. In rats,
48

short-term overfeeding increases norepinephrine turnover at the heart,
indicating activation of the sympathetic nervous system (Landsberg & Young,
1978). Dogs also exhibit significant increases in norepinephrine after 1 week
of being overfed a high fat diet (Rocchini, Moorehead, DeRemer, & Bondie,
1989). In humans, norepinephrine turnover in plasma increases significantly
with elevated energy intake (O'Dea, Esler, Leonard, Stockigt, & Nestel, 1982).
These studies demonstrate a clear evolutionarily conserved pattern in
mammals, that acute overfeeding induces sympathetic activation. Landberg
postulated that overeating stimulates the sympathetic nervous system in
order to initiate thermogenesis and stabilize body weight (Landsberg, 1986)
Unfortunately, the increase in sympathetic activity influences the vasculature
and thus increases blood pressure. These studies laid the foundation for
postulating that human obesity is characterized by sympathetic activation and
increases the risk for hypertension. Increased sympathetic activity has been
confirmed by measuring significantly elevated renal norepinephrine spillover
and muscle sympathetic nerve activity in obese individuals (Grassi et al.,
1995; Vaz et al., 1997). However, even without overeating energy intake
induces sympathetic activation. Sections 2.4.1 and 2.5.2 will explore how
energy intake influences autonomic balance.

2.4.1 Cardiovascular Responses to Food Ingestion
The consumption of food begins a cascade of physiological processes
essential for the maintenance of life. Almost every major biological system
responds to the ingestion of food. Macronutrient composition (% protein, %
fats, % carbohydrate) of a meal is a contributing factor to the physiological
responses to food consumption, with carbohydrates having the most
influence. This section will highlight literature in which carbohydrates
consumed during a meal were adequate so that glucose production was not
required liver. Due to the fact that if a meal is deficient in carbohydrates,
insulin is still released at a greater rate than basal, causing the liver to initiate
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gluconeogenesis to maintain blood glucose concentrations (Cahill Jr, 1978).
Essentially, when meals are consumed with low-carbohydrates, the liver
produces glucose as if no meal had been consumed.
Following a meal there is an increase in energy expenditure,
commonly referred to as the thermogenic effect of food. (K. Acheson, Jéquier,
& Wahren, 1983; K. J. Acheson, Ravussin, Wahren, & Jéquier, 1984). This
increase in energy expenditure is accompanied by an increase in sympathetic
nervous system activity. Increased sympathetic nervous system activity has
been demonstrated by postprandial rises in both systemic and local (adipose
tissue) norepinephrine spillover (Patel, Eisenhofer, Coppack, & Miles, 1999),
and increases in muscle sympathetic nerve activity (Berne, Fagius, &
Niklasson, 1989; C. N. Young, Deo, Chaudhary, Thyfault, & Fadel, 2010).
This increase in MSNA can last up to 2 hours post ingestion (C. N. Young et
al., 2010). Meal ingestion will also cause a rise in insulin, which facilitates an
increase in arterial baroreflex gain of MSNA (C. N. Young et al., 2010).
Spontaneous cardiac baroreflex sensitivity is not affected by meal ingestion
(C. N. Young et al., 2010). After a meal, splanchnic blood flow and cardiac
output will increase (Høost et al., 1996). The increase in cardiac output
compensates for the postprandial fall in total peripheral resistance resulting in
no, or very little decrease in blood pressure (Sidery, Macdonald, Cowley, &
Fullwood, 1991). In general, after a meal local vasodilation occurs in
splanchnic areas, adipose tissue, and the heart but not in other areas such as
the limbs, skeletal muscle, and the kidney (van Baak, 2008). The sympathetic
response to food ingestion is essential for the maintenance of arterial
pressure, as cardiac output is shunted to visceral areas. An example of the
importance of the sympathetic response to food ingestion can be seen in
individuals with autonomic dysfunction and in the elderly. After a meal, elderly
individuals and those with autonomic dysfunction can experience postprandial hypotension, resulting in a profound decrease in both systolic and
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diastolic blood pressure (Jansen & Lipsitz, 1995; Robertson, Wade, &
Robertson, 1981). Post-prandial hypotension can result in dizziness, syncope,
and falls (Aronow & Ahn, 1997), highlighting the importance of
sympathetically mediated cardiovascular responses to food ingestion.

2.4.2 Hormonal Responses to Food Ingestion
Postprandial hormonal responses are important for the initiation of
thermogenesis, satiety, and maintenance of blood glucose concentrations.
BMI and sex can influence some key baseline circulating hormones and their
response to meal consumption. Obese subjects have greater increases in
insulin and glucose when compared to normal weight subjects (Carroll,
Kaiser, Franks, Deere, & Caffrey, 2007). Circulating levels of ghrelin are also
lower in obese individuals. Obese individuals experience little to no change in
ghrelin levels upon meal consumption, while lean subjects exhibit significant
declines in circulating ghrelin after a meal (English, Ghatei, Malik, Bloom, &
Wilding, 2002). Stress hormones such as cortisol (Stimson et al., 2014) and
norepinephrine increase after a meal (Astrup, Simonsen, Bulow, Madsen, &
Christensen, 1989). The importance of norepinephrine for initiating
postprandial increases in energy expenditure and glucose uptake was
demonstrated in a study utilizing β-adrenoreceptor blockade. After the
blockade, postprandial increases in energy expenditure and glucose uptake
were blunted (Astrup et al., 1989). Circulating epinephrine levels exhibited a
significant decrease immediately after a meal (Astrup et al., 1989; Penev,
Spiegel, Marcinkowski, & Van Cauter, 2005). There are sex specific
differences in the hormonal responses to food ingestion. Men have greater
baseline and postprandial glucagon and a slightly greater decline in leptin
after a meal compared to women (Carroll et al., 2007). In men, meal
consumption also temporarily reduces serum testosterone (Habito & Ball,
2001). The influence of meal consumption on estradiol in women has not
been studied. However, estradiol replacement therapy improves postprandial
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lipid metabolism and endogenous estrogens attenuate postprandial lipemia
(Westerveld, 1998). The cardioprotective benefits of estrogen could partially
be due to estrogen’s beneficial influence on lipid metabolism.

2.5 The Influence of Fasting on Autonomic Balance
In the 1970’s Lewis Landsberg and John Young set out to investigate
how acute fasting influenced the sympathetic nervous system in rats. Their
initial hypothesis was that fasting would increase sympathetic activation as
fasting initiates mobilization of fat stores and was thought to be “stressful,”
overall. However, in an elegant study they found that after 48 hours of food
deprivation there was a marked suppression of sympathetic activity (James B
Young & Landsberg, 1977). They measured sympathetic activation at the
heart using the norepinephrine turnover technique. They found that fasting
significantly reduced norepinephrine turnover at the heart indicating reduced
sympathetic activity. This study was repeated in 1982 and they again found
reduced norepinephrine turnover at the heart that was associated with
decreased blood pressure in hypertensive rats (Einhorn, Young, & Landberg,
1982). Initially these findings were counterintuitive to the group because if
sympathetic activity is suppressed how do fat stores get mobilized? In
another series of studies Lewis and Landberg discovered that in the fasted
state sympathetic activity at the heart is disassociated from sympathetic
activity at the adrenal medulla. They reported that in fasted rats the adrenal
medulla increases secretion of epinephrine and norepinephrine while cardiac
sympathetic activity remains suppressed (J. B. Young, Rosa, & Landsberg,
1984). Landsberg and Lewis’s work laid the foundation for our understanding
of how fasting influences the autonomic nervous system. Nevertheless,
translating this work to humans is difficult because a rat’s metabolic rate is
much higher. Rats heart rate is on average 4 fold faster than humans and
their metabolic rate is ~6 fold faster than humans (Agoston, 2017). The
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following sections will discuss how short-term fasting affects the autonomic
nervous system and hormonal responses to energy deprivation.

2.5.1 Cardiovascular Responses to Short-term fasting
Short term fasting is defined as a period of complete caloric cessation
lasting from 12 to 72 hours. When compared to food consumption, an
overnight fast (~12 hours) enhances parasympathetic modulation of the heart
as suggested by a study utilizing spectral analysis of heart rate variability. The
overnight fasting study measured no change in heart rate, decreased LF/HF
ratio and increased HF power in the fasting group (Kuwahara, Okita, Kouda,
& Nakamura, 2011). A follow-up study by the same group repeated the
overnight fasting study but in women during the follicular and luteal menstrual
phases. The primary findings were that heart rate decreased during fasting in
both phases, HF power increased during fasting during both phases and
salivary cortisol was decreased during the fasting luteal phase (Ohara et al.,
2015). However, a similar overnight fast vs. fed comparison done in an older
sample population (~59±9 yrs; mean±SD) was unable to replicate the
changes in HF power and even reported an increase in diastolic pressure
(Rodrigues et al., 2019).
Few studies have utilized a 24-hour fasting time point in humans. Herbert
et al., conducted a study in 20 healthy young women who fasted for 24 hours
in a metabolic ward. Herbert’s study in 20 women reported that fasting for 24hours increased heart rate and cardiac output and decreased high-frequency
normalized units of spectral power (Herbert et al., 2012). Mazurak et al.,
studied 16 healthy women and was unable to replicate the changes in heart
rate or heart rate variability after 24-hours of fasting. Interestingly, Mazurak
reported a numerical but not statistically significant increase in RRI and heart
rate variability (SDNN, RMSSD, HFnu) at 24 hours fasted. However, after 48
hours of fasting Mazurak reported a decrease in SDNN, a time domain
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indicator of heart rate variability. Marurak et al., included a tilt test and
reported that after 24 & 48 hours of fasting participants exhibited greater
vagal withdrawal when exposed to tilt. Vagal withdrawal was indicated by
decreased RRI, SDNN, and LogHF power (Mazurak et al., 2013). Greater
vagal withdrawal and increased heart rate responses to head-up tilt were also
exhibited after a 72-hour fast (S. J. Brown, Bryant, Mündel, & Stannard,
2012). It should be noted that the studies conducted by Mazurak and Herbert
were done exclusively in women and they did not control for menstrual cycle
or for breathing during heart rate variability measurements.
A cornerstone study in understanding the influences of acute fasting in
humans was conducted by Webber and Macdonald. Webber and Macdonald
investigated the influence of fasting for 12, 36, and 72 hours on
cardiovascular and hormonal changes in 29 (17F) individuals. The 36-hour
and 72-hour timepoints were compared to the 12-hour fasting timepoint. The
authors reported that fasting did not change blood pressure but increased
heart rate at both the 36- and 72-hour timepoint. Forearm blood flow was
significantly increased at the 36- and 72-hour time point and plasma
epinephrine and norepinephrine increased at the 72 hours fasted (J. Webber
& Macdonald, 1994). Webber and Macdonald repeated their fasting study and
they again found that heart rate and forearm blood flow increased at 36 and
72 hours fasted compared to the 12 hour fasted timepoint (J Webber et al.,
1995). It was suggested that forearm vasodilation found could potentially be
caused by the significant increase in ketones (J Webber et al., 1995).
However, there is an important methodological caveat to the studies
conducted by Macdonald and Webber. Both studies compare the 36-hour and
72-hour fasting timepoint to an overnight fast of ~12-hours. At the beginning
of this section, it was highlighted that a 12-hour fast may enhance
parasympathetic activity at the heart (Kuwahara et al., 2011; Ohara et al.,
2015). The studies by Macdonald and Webber report an increase in
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sympathetic activity, measured via heart rate and blood catcholamines, as
fasting reaches 36 and 72 hours. However, because they are comparing their
time points to a 12 hour fast, how fasting influences autonomic activity at 1224 hours post caloric cessation remains equivocal.
To date, only one study has directly measured sympathetic neural outflow
in fasted participants. The study was conducted in 11 obese middle-aged
women, before and after a 48 hour fast. Only 6 nerves were recorded, and
they reported a slight but statistically significant increase in muscle
sympathetic nerve activity (42.0±5.5 vs. 44.5±5.8 bursts/min) (Andersson,
Wallin, Hedner, Ahlberg, & Andersson, 1988). Counterintuitively, the authors
also reported a reduction in systolic and diastolic blood pressure in response
to the 48 hour fast (Andersson et al., 1988).
In conclusion, short-term fasting influences autonomic balance and the
cardiovascular system. While the influence of fasting on autonomic activity is
equivocal at the early hours post caloric cessation (~12-24 hours) as fasting
time extends a clear shift towards increased sympathetic activity occurs. This
dissertation seeks to elucidate the influence of a 24 hour fast on autonomic
activity.

2.5.2 Hormonal Responses to Short-term Fasting
Short-term fasting alters blood biomarkers and circulating hormone
concentrations. A 24-hour water only fast that focused on blood biomarker
expression reported that participants increased human growth hormone and
circulating cholesterol levels in the fasted state (Horne et al., 2013).
Additionally, participants in the fasted state exhibited increased red blood cell
count and hemoglobin without loss in plasma volume (Horne et al., 2013).
Leptin serum levels fall by ~50% after a 24 hour fast (Boden, Chen, Mozzoli,
& Ryan, 1996). After 12-hours of fasting ghrelin levels increase ~31%
(Ariyasu et al., 2001). However, upon the cessation of food intake ghrelin
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secretions take on a diurnal pattern, increasing at habitual meal times
(Natalucci, Riedl, Gleiss, Zidek, & Frisch, 2005). Ghrelin also tends to be
higher in females and has a strong inverse relationship to cortisol in the
fasted state (Espelund et al., 2005). Serum insulin continuously decreases
during the first 30 hours of fasting; meanwhile plasma glucagon continuously
increases during 72 hours of fasting (Højlund et al., 2001). Both plasma
epinephrine and norepinephrine concentrations fluctuate in a circadian rhythm
during fasting. Studies have reported significant increases in plasma
epinephrine and norepinephrine during fasting at the 24-, 48-, and 72-hour
time points (Højlund et al., 2001; J. Webber & Macdonald, 1994). Plasma
glucose steadily decreases until it plateaus after approximately 2 days of
fasting (Haymond, Karl, Clarke, Pagliara, & Santiago, 1982; Højlund et al.,
2001) Concurrently, ketones (β-hydroxybutyrate) progressively increase as
fasting time continues (Haymond et al., 1982; J. Webber & Macdonald, 1994).
Notably, women have higher concentrations of ketones during fasting when
compared to men (Merimee et al., 1978).
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3 EXPERIMENTAL APPROACH
3.1 Research Methods Common Across Aims 1-3
3.1.1 Subject Inclusion and Exclusion Criteria
Male and female participants between the ages of 18 and 40 years
were invited to participate. Participants received a verbal briefing from the
Principal Investigator or Co-Investigator, and a written description of all
procedures and risks associated with the experiment was provided. Voluntary
written informed consent to participate in the study was obtained. Because of
the potential effect on vascular volume and autonomic control, participants
were asked to refrain from exercise and stimulants such as caffeine, cold
medications that might alter autonomic function (e.g., those containing
diphenhydramine), and alcohol 24 hours prior to autonomic testing. Because
of the potential influence of ovarian hormones on autonomic function (Carter
et al., 2013; Minson et al., 2000), all female participants were tested in the
early follicular phase of their menstrual cycles (days 3 to 8). Participants
visited the laboratory for a familiarization session before the first day of
experimentation, during familiarization all procedures and equipment were
explained to them and they had the opportunity to ask questions of the
investigators. Participants read and signed an informed consent document
that was approved by the Committee for the Protection of Human Subjects in
Research at Michigan Technological University.
All Participants filled out an information sheet prior to being officially
enrolled in the study (Appendix A.1). This information sheet was used to
generate an alphanumerical code (e.g. AA001) that was assigned to that
participant for the duration of the study. Thus, all electronic data files are
unidentifiable in the unlikely event of an electronic security breach. Paper files
containing the participant’s information are treated with strict confidentiality.
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Participant Inclusion:
•

Individuals between the ages of 18-40 years old

•

All women tested in early follicular phase

•

Individuals able to not eat for 24 hours

Participant Exclusion:
•

Individuals who have been diagnosed with diabetes

•

Individuals who have a history of blood clots

•

Individuals with a history of hyperthyroidism

•

Women currently taking oral contraceptives, are pregnant or trying to
become pregnant

•

Individuals with respiratory illnesses (e.g. asthma, chronic obstructive
pulmonary disease, reactive airways disease, etc.)

•

Hypertensive (Systolic ≥130 mmHg and/or diastolic ≥80 mmHg)

•

Individuals with a history of tobacco or vaporized nicotine use

3.1.2 Measurements
•

Actigraphy: Actigraphy was used to determine sleep/wake patterns and
to confirm compliance to requirements. Subjects will continuously wear a
wrist actiwatch (Respironics, Murrysville, PA) to monitor 24-hour activity
levels (1 min epoch) on the days of monitoring. This is a safe, noninvasive
procedure that poses no risk to the subjects.

•

Ambulatory Blood Pressure Monitor: The ABPM is a lightweight battery
powered device that measures blood pressure using an arm cuff 3 times
per hour during the day time and 2 times per hour during the programmed
sleep time.
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•

Electrocardiogram: 3-lead ECG for identification of R-waves for timeand frequency domain analysis of heart rate variability.

•

Finger Photoplethysmography: A finger cuff housing an infrared sensor
was placed on the middle finger and equilibrated to brachial arterial
pressure with a servo motor (Finometer, Finapres Medical Systems,
Arnhem, Netherlands) to record beat-by-beat arterial pressures from the
finger.

•

Muscle Sympathetic Nerve Activity: Muscle sympathetic nerve activity
(MSNA) was measured directly with a Nerve Traffic Analyzer (Model
662C-2, University of Iowa Bioengineering, Iowa City, IA). To accomplish
this, multifiber efferent sympathetic nerve traffic from peroneal nerve
muscle fascicles at the popliteal fossa was recorded with tungsten
microelectrodes (Frederick Haer and Co., Bowdoin, ME). The course of
the nerve was mapped by stimulating the nerve through the skin with a
pencil shaped electrode (10 - 50 v; 0.1 ms duration). Once the nerve was
located, two sterile wire electrodes (diameter approximately 0.2 mm) were
introduced through the skin at a depth of approximately 0.5 – 1 cm; one
electrode served as the ground, and the other as the recording electrode
inserted directly into the nerve. Both electrodes were connected to a
differential preamplifier and then to an amplifier (total gain of 90,000),
where the nerve signal was band-pass filtered (700-2000 Hz) and
integrated (time constant 0.1 s) to obtain mean voltage neurograms. The
recording electrode was manipulated into the region of the nerve until a
characteristic “bursting” sound was detected. At this point minute
adjustments were made to the electrode position until adequate
sympathetic recordings were observed and maintained. Satisfactory
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recordings of MSNA were defined by spontaneous, pulse-synchronous
bursts that do not change during tactile or auditory stimulation.
•

Limb Plethysmography. Limb blood flow was measured from the
forearm using venous occlusion plethysmography (D.E. Hokanson,
Bellevue, WA, USA). A mercury-in-silastic strain gauges was placed
around the maximal circumference of the forearm. A wrist cuff was
inflated to 220 mmHg to arrest circulation to the hand. An arm cuff was
inflated (~70mmHg) and deflated (0 mmHg) in 7-8 sec intervals (15
sec/cycle). This technique allows for occlusion of venous blood flow, but
still allows arterial blood flow. A strain gauges was used to measure
diameter changes during these inflation/deflation cycles. Vascular
resistance was calculated as mean arterial pressure divided by limb blood
flow, and vascular conductance was calculated as the reciprocal of
vascular resistance. This technique is a time-honored, safe, and
noninvasive method for estimating limb blood flow (M. J. Joyner, Dietz, &
Shepherd, 2001).

•

Pneumobelt: A strain gauge was secured around the lower ribcage to
record respiratory rate.

3.1.2.1 Integrated Data Analysis
In addition to our primary measurements of interest, a series of secondary
integrated analysis will be performed using two or more signals
•

Spontaneous Cardiovagal Baroreflex Sensitivity: Spontaneous
cardiovagal BRS was determined by beat-to-beat changes in R-R interval
and systolic pressure using the sequence method (Blaber, Yamamoto, &
Hughson, 1995). Within the time domain baroreflex was assessed by
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identifying sequences of three or more consecutively increasing systolic
pressures (SAP) that correspond to 3 or more consecutively lengthening
R-R intervals (up-up sequences, vagal activation). Additionally, systolic
pressures that exhibit 3 or more decreases and 3 or more consecutive
shortenings of R-R intervals was identified (down-down sequences, vagal
inhibition). Systolic pressures that changes by at least 1 mmHg per beat
and R-R- intervals that change by at least 4 ms was identified as a
sequence. Linear regression was used to determine the slope of the linear
relationships between R-R intervals and SAP for each sequence.
•

Dynamic Baroreflex Sensitivity (Valsalva Maneuver): The Valsalva
maneuver provokes reproducible changes in arterial pressure which
triggers autonomic responses to expiratory strain. Phases of the Valsalva
strain were determined by the arterial pressure waveform. The beginning
of phase 2 was defined as the highest systolic pressure reached before
arterial pressure begins to fall. The end of phase 2 was defined as the first
systolic pressure that increases after the falling period. Phase IV was
identified by the first pressure value that increases after release from the
strain and continues until the first noticeable drop after overshoot.
Cardiovagal BRS was determined by calculating the slope between SAP
and R-R interval during phase II and IV of strain (Yamazaki et al., 2003).

3.1.2.2 Identification of Fasting Compliance
Fasting for 24 hours can be difficult. To assure fasting compliance, and
also to have a means to quantify the effect of the fast as a stimulus we
measured blood glucose, blood ketones, and lipids. The lipid profile quantified
total cholesterol, high-density lipoprotein, low-denisity lipoproteins,
triglycerides, and glucose using an Alera Cholestech LDX analyzer. Blood
ketones were measured using a Precision Xtra ketone monitor.
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Measurements were taken before each autonomic test. Ketones are
produced 8 to 12 hours after caloric cessation to levels around 0.2 to 0.5 mM
which is maintained through 24 hours (Cahill Jr, 1978). Fasting for 24-hours
decreases glucose by ~8 mg/dL, and triglyerides ~50 mg/dL while increasing
total cholesterol by ~ 9 mg/dL (Horne et al., 2013). At least one of these
criteria was met for a fast to be considered successful.
3.1.2.3 Standardized Meal
A standardized lunch (Appendix A.2 & A.3) was provided as the last meal
consumed before the fed and fasted experimental protocols. Resting
metabolic rate calculations were estimated using the Mifflin-St. Jeor equation
(Frankenfield, Roth-Yousey, & Compher, 2005).
•

Male: RMR = 9.99 x weight(kg) + 6.25 x height(cm) – 4.92 x age + 5

•

Female: RMR= 9.99 x weight(kg) + 6.25 x height (cm) – 4.92 x age –
161

The RMR estimate was then multiplied by a Harris-Benedict physical
activity factor to estimate total daily energy needs to maintain the participants
given weight. Caloric content of the meal was estimated to be 1/3 of total
caloric intake needed to maintain weight.
•

Calories needed = RMR X Activity factor

•

Activity Factor = Sedentary: 1.2; Mild: 1.375; Moderate: 1.55; Heavy:
1.725; Extreme: 1.9

3.1.2.4 Assessment of Hydration Status
Urine was collected before each autonomic testing session. To assess
hydration status urine specific gravity was obtained using a PALS-10S urine
refractometer (Atago, Tokyo, Japan).
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3.2 Specific Aims, Experimental Protocol, and Power
Analysis
3.2.1 Specific Aims
Specific Aim 1: Determine the influence of a 24-hour fast
on hemodynamics, peripheral neural activity, and
cardiovascular control at rest.
Hypothesis Aim 1: Acute fasting will reduce blood
pressure, muscle sympathetic nerve activity, and heart
rate. Fasting will also enhance parasympathetic
modulation of the heart and enhance baroreflex
sensitivity
Specific Aim 2: Determine the influence of a 24-hour fast
on neural and cardiovascular responses to mental
stress.

Hypothesis Aim 2: Acute fasting will reduce
cardiovascular and neural reactivity to mental stress

Specific Aim 3: Determine the influence of a 24-hour fast
on neural and cardiovascular responses to a severe
orthostatic stress.

Hypothesis Aim 3: Acute fasting will reduce tolerance to
a severe orthostatic stress by reducing cardiovascular
and neural reactivity to lower body negative pressure
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3.2.2 Experimental Design
This study is a randomized controlled crossover design with repeated
measures. The two conditions are the fed condition which is defined as 3
hours postprandial and the fasted condition which is defined as 24 hours post
prandial. The conditions were randomized, and participants were informed 3
days before scheduled autonomic testing which condition, they were
assigned. For example, if they were assigned to the fed condition for the first
autonomic test 4 weeks later, they would be fasted for the autonomic function
test. Participants would report to the lab 24 hours before their scheduled
autonomic test to be fitted with an actigraphy watch and ambulatory blood
pressure cuff. The experimental protocol is summarized in figure 3.
Figure 3: Experimental Design
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3.2.3 Power Analysis
We used a two-tailed paired samples t-test to estimate power based on data
from a recent publication that specifically investigated acute fasting time in
humans using heart rate as the primary variable of interest (Ohara et al.,
2015) Using the heart rate mean and SD (Fed = 65±5 & Fasted 61±5) from
Ohara et al., we calculated an effect size of 0.8. With an α = 0.05 and a β =
.95 we estimated that a sample size of 23 participants would give us sufficient
power. We tested a total of 25 participants.
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4 RESULTS AND CONTROLS COMMON ACROSS
AIM 1-3
4.1 Participant Characteristics
Twenty-five heathy young adults (14 men and 11 women) were recruited
to participate in this study. All participants had no history of autonomic
dysfunction, hypertension, respiratory disease, diabetes, or nicotine usage,
and were not taking any prescription medications. Participant eligibility was
evaluated through study orientation where they were informed of the purpose
of the study, what would be asked of them, and the potential risks. Informed
consent was obtained during the orientation visit.
Table 1: Participant Characteristics
Baseline Participant Characteristics at Orientation
N

25 (11F)

Age, yrs

23±3

Height, cm

176±16

Weight, kg

76±16

BMI, kg/m2

24±4

Systolic, mmHg

110±12

Diastolic, mmHg

67±6

Heart Rate, BPM

71±14

Values are mean ± SD
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4.2 Blood Biomarkers
Blood biomarkers were collected to ensure fasting compliance and to
ensure that a 24-hour fast was a sufficient stimulus to intiate ketone
production. Participants were weight stable and similarly hydrated between
conditions. Blood triglycerides and glucose were significantly decreased in the
fasted condition compared to the fed condition. Blood ketones were
significantly increased in the fasted condition compared to the fed condition.
The magnitude of change in glucose, triglycerides, and ketones between the
fed and fasted condition are similar to previously published literature
investigating blood biomarkers after a 24 hour fast (Cahill Jr, 1978; Horne et
al., 2013). Specific gravity was collected in 23 participants because 2
participants could not produce a urine sample at the start of the experimental
session.
Figure 4: Pertinent Blood Biomarkers

Blood biomarkers represented as boxplots. The line in the boxplots represents the
median and the box represents the interquartile range (IQR; the difference between the
25th and 75th percentile. The Whiskers extend from the upper and lower edge of the box
to the 10th and 90th percentile values. *p<0.05; **p<0.01; ****p<0.0001
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Table 2: Blood Biomarkers

Variable

Fed

Fasted

MD

t-test
p-value

Weight, kg

76.3±15.4

75.6±15.2

0.7±0.6

.271

Urine Specific
Gravity, A.U.
(N=23)

1.015±.002

1.011±.002

.004±.002 .113

Total Cholesterol,
mg/dL

172.4±35.2

172.7±29.1

0.3±4

.937

Low-Density
Lipoprotein, mg/dL

95.6±29.9

105.5±21.5

5.8±5

.253

High-Density
Lipoprotein, mg/dL

58.8±18.9

56.2±20.3

2.4±1.6

.151

Triglycerides,
mg/dL

120.8±61.6

77.2±37.9**

Glucose, mg/dL

98.8±11.7

80.9±8.0**

Ketones, mmol/L

.128±.13

.536±.49**

Wilcoxon
p-value

.003
18±2.6

<.001
<.001

(β-hydroxybutyrate)

Values are mean ± SD. Paired t-tests were used to compare variables between the
fed and fasted condition. Wilcoxon matched-pairs signed rank test used to compare
variables not normally distributed. MD = mean difference between the fed and fasted
condition Two-tailed p-values are displayed. (*) = p ≤ 0.05 (**) = p ≤ 0.01

4.3 Actigraphy
Participants wore Actiwatch Spectrum PRO watches for the 24 hours
leading up to the autonomic testing session. Inclusion of actigraphy was
primarily to ensure that participants were able to sleep while fasting and to
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properly calibrate the ambulatory blood pressure data points to the wake and
sleep times. Actigraphy was successfully collected in 22 participants. 3
Participants had unsuccessful readings during one of the conditions. 2
Participants removed the watch and forgot to replace it in a timely manner
and 1 participant experienced equipment failure. Participants in the fasted
condition experienced more awakenings, spent more time in bed and got an
extra hour of sleep on average when compared to the fed condition. However,
minutes active, wake after sleep onset (WASO) and sleep efficiency were not
different between the conditions.
Table 3: Actigraphy Data
Variable

Fed

Fasted

MD

t-test
p-value

Time in Bed, hours

7.7±1.7

8.9±1.9**

1.3±0.4

.005

Total Sleep Time,
hours

6.6±1.5

7.6±1.6*

1.1±0.4

.011

Sleep Efficiency, %

84.7±6.7

85.4±4.4

0.7±1.3

.610

Sleep Latency, min

15.3±18.1

22.0±17.8

8.6±5.6

.140

Awakenings, #

30±12.0

35.8±14.3*

5.5±2.5

.037

WASO, #

35.2±15.8

37.9±17.9

1.7±3.7

.644

Activity Minutes

612.3±234.6

588.19±361.7 19.6±60.7 .750

Values are mean ± SD. Paired t-tests were used to compare variables
between the fed and fasted condition. MD = mean difference between the fed
and fasted condition Two-tailed p-values are displayed. (*) = p ≤ 0.05 (**) = p
≤ 0.01
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5 THE INFLUENCE OF AN ACUTE FAST ON 24-HOUR
AMBULUATORY BLOOD PRESSURE
5.1 Introduction
Cardiovascular disease remains the leading cause of death in the
United States. Hypertension (SAP ≥130 mmHg or DAP ≥80 mmHg) is
associated with an increased risk of ischemic heart disease and cardiac
failure (Wilson, 1997). Hypertension is a treatable risk factor, that when
controlled can mitigate the risk cardiovascular disease. Physicians have a
variety of pharmaceuticals at their disposal that do assist in the management
of hypertension and reduce the risk of cardiovascular disease (Glynn,
Murphy, Smith, Schroeder, & Fahey, 2010). However, observational studies
have reported that almost half of hypertensive patients taking medications do
not meet their target blood pressure (Reid et al., 2008). Therefore, despite
pharmaceutical treatment hypertension remains a major public health concern
and risk for cardiovascular disease. It is important to understand which
components of blood pressure influence risk.
The Framingham Heart Study contributed significantly to our
understanding of the relationship between blood pressure and heart disease.
Specifically, the Framingham Heart study was able to distinguish the
contribution of systolic versus diastolic blood pressure to risk of coronary
heart disease (CHD). The study reported that in those under the age of 45
diastolic was the dominant predictor of CHD risk. However, as people age
systolic blood pressure becomes the more reliable predictor (Kannel, Gordon,
& Schwartz, 1971). Later, pulse pressure was also identified as an important
component of risk of CHD (Franklin, Khan, Wong, Larson, & Levy, 1999).
Pulse pressure is the difference between systolic pressure and diastolic and
correlates with arterial stiffness (Mitchell et al., 2010).
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Lifestyle interventions such as diet and exercise are well known to assist
in reducing blood pressure (Bruno, Amaradio, Pricoco, Marino, & Bruno,
2018) Recently, it has been reported that chronic intermittent fasting can
potentially lower both systolic and diastolic blood pressure (Malinowski et al.,
2019). However, how fasting influences blood pressure acutely is unknown.
Therefore, the purpose of this study was to determine how fasting for 24
hours influences 24-hour ambulatory blood pressure. Specifically, we will test
the hypothesis that acute fasting lowers systolic, diastolic, and pulse pressure
compared to normal eating.

5.2 Methods
5.2.1 Data Collection
24-hour ambulatory blood pressure monitor (ABPM) data were collected
twice once in the fed state (3-hours post prandial) and once in the fasted state
(24-hours postprandial) separated by 4 weeks. Sampling frequency was set
to collect brachial blood pressures every 20 min between 0700 and 2200
hours and every 30 min from 2200 to 0700 hours. Participants were instructed
to immobilize their arm upon cuff inflation and to only remove the cuff for
showering. Participants wore the cuff for a continuous 24-hour period.
Daytime and nighttime blood pressure values were defined by the actigraphy
watch. Participant characteristics and actigraphy data can be found in chapter
4.

5.2.2 Data Analysis
To be included in this data set a minimum of 20 daytime measurements
and a minimum of 7 nighttime measurements were needed for each
condition. 20 participants were included in this data set. Two participants
were eliminated for device failure and 3 participants were eliminated for not
meeting the minimum requirement for successful readings for both conditions.
Daytime and nighttime blood pressure values were adjusted to reflect
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actigraphy wake time, sleep time, and sleep latency. Fed vs. fasted conditions
were compared using a paired t-test. Normality was assessed using a
Shapiro-Wilk test. If data were found to be not normally distributed a Wilcoxon
matched pairs signed rank test was used to assess dependent variables.
Two-tailed p-value <0.05 was considered statistically significant for all tests.
The table below shows quality and quantity of ABPM readings per condition.
Table 4: Ambulatory Blood Pressure Data Quality
Fed

Fasted

Reading Success, %

74±12

78±13

Average Wake Recordings, #

32±7

34±8

Average Sleep Recordings, #

13±3

15±5

Total Brachial Recordings, #

902

970

Data presented are mean ± SD

5.3 Results
5.3.1 Overall Blood Pressure
Fasting significantly reduced overall systolic and mean arterial
pressure when compared to the fed condition. In total 902 brachial blood
pressures were averaged from the fed condition and 970 brachial blood
pressures were averaged from the fasted condition. Heart rate was also
significantly reduced during the fasted state. However, heart rate was
estimated from the blood pressure cuff and not an ECG. Overall pulse
pressure and diastolic blood pressure were not statistically different between
the two conditions but tended to decrease.
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Figure 5: Overall Ambulatory Systolic and Mean Blood Pressure

Overall Systolic (SAP) and mean arterial pressure (MAP) represented as boxplots. The
line in the boxplots represents the median and the box represents the interquartile range
(IQR; the difference between the 25th and 75th percentile). The whiskers extend from the
upper and lower edge of the box to the highest and lowest values. *p<0.05

Table 5: Overall Ambulatory Blood Pressure Data
Variable

Fed

Fasted

MD

t-test
p-value

Overall SAP

110±1.7

108±1.5*

2.2±1

.045

Overall DAP

64±1.3

63±1.3

1.6±1

.074

Overall MAP

81±1.2

78±1.2*

2.1±1

.039

Overall Pulse Pressure

47±1.4

46±1.2

1±0.5

.106

Overall Heart Rate

69±1.9

65±2.2**

3.9±1

.003

Values are mean ± SE. Paired t-tests were used to compare variables between the
fed and fasted condition. MD = mean difference between the fed and fasted
condition Two-tailed p-values are displayed. (*) = p ≤ 0.05 (**) = p ≤ 0.01
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5.3.2 Wake Blood Pressure
Wake blood pressure readings were verified via actigraphy watch.
Fasting significantly reduced wake systolic blood pressure and wake heart
rate. Diastolic and mean arterial pressure were similar between conditions.

Figure 6: Wake Ambulatory Systolic and Heart Rate

Wake Systolic (SAP) and heart rate (MAP) represented as boxplots. The line in the
boxplots represents the median and the box represents the interquartile range (IQR; the
difference between the 25th and 75th percentile). The whiskers extend from the upper and
lower edge of the box to the highest and lowest values. *p<0.05; ***p<.0001
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Table 6: Wake Ambulatory Blood Pressure Data
MD

t-test
Wilcoxon
p-value p-value

Variable

Fed

Fasted

Wake SAP

115±2.0

113±1.8*

Wake DAP

69±1.5

68±1.6

1.5±1 .270

Wake MAP

85±1.5

83±1.5*

1.7±1 .145

Wake Pulse
Pressure

46±1.3

43±2.1

Wake Heart Rate

74±2.0

68±2.4**

.018

.371
5.4±1 <.001

Values are mean ± SE. Paired t-tests were used to compare variables between the fed and
fasted condition. Wilcoxin matched-pairs signed rank test was used to test variables not
normally distributed. MD = mean difference between the fed and fasted condition Twotailed p-values are displayed. (*) = p ≤ 0.05 (**) = p ≤ 0.01
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5.3.3 Sleep Blood Pressure
Fasting did not affect nighttime blood pressure values or nighttime
dipping patterns.

Table 7: Sleep Ambulatory Blood Pressure Data
Variable

Fed

Fasted

MD

p-value

Sleep SAP, mmHg

100±1.5

99±1.2

1±1.4

.550

SAP Dip, %

13±1.4

12±1.1

0.4±1.1 .737

Sleep DAP, mmHg

54±1.2

53±1.0

1±1.1

.346

DAP Dip, %

21±1.5

20±1.5

0.8±2

.704

Sleep MAP

72±1.1

70±1.0

2±1.2

.163

MAP Dip, %

15±1.3

16±1.2

0.7±1.6 .669

Sleep Pulse Pressure

46±1.2

45±0.9

0.3±1

.822

Sleep Heart Rate

59±1.9

57±2.3

2±1.4

.271

Values are mean ± SE. Paired t-tests were used to compare variables between the fed and
fasted condition. MD = mean difference between the fed and fasted condition Two-tailed pvalues are displayed. (*) = p ≤ 0.05 (**) = p ≤ 0.01

5.4 Discussion
In young healthy normotensive individuals, acute fasting reduces overall
24-hour ambulatory blood pressure and heart rate. Additionally, fasting tends
to reduce wake pulse pressure. Blood pressure is a functional product of
cardiac output and peripheral resistance. Heart rate was significantly reduced
while fasting, suggesting that decreased cardiac output may potentially be
causing the measured reduction in blood pressure. The mechanism behind
this reduction in blood pressure warrants further exploration.
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The reductions in arterial pressure we measured are mild and acute (Δ2
mmHg SAP, Δ3 mmHg MAP). However, reductions in arterial pressure
associated with fasting are similar in magnitude to the 24-hour post exercise
hypotension measured after a single bout of resistance exercise (Δ1.7 mmHg
SAP) (Casonatto, Goessler, Cornelissen, Cardoso, & Polito, 2020). Fasting
may be an alternative for those who still want the acute hypotensive effects of
exercise but are unable to make it to the gym. In a majority of individuals
seeking to lower their blood pressure, reducing systolic blood pressure is
particularly difficult (Chobanian et al., 2003). Thus, it is important to recognize
that acute fasting primarily reduces the systolic component of blood pressure.
Controlling systolic blood pressure is the most crucial component when
assessing risk of future cardiovascular disease (Kannel et al., 1971).
Chronic intermittent fasting regimens of 8 to 12 weeks have been
reported to reduce blood pressure (Malinowski et al., 2019). Our study is the
first to report the acute hypotensive effects of fasting over a 24-hour period.
Recently, a study demonstrated that medically supervised fasting lasting 4 to
41 days (average 10 days) can significantly reduce blood pressure (Grundler,
Mesnage, Michalsen, & Toledo, 2020). However, fasting for multiple days is
difficult and can interfere with individuals’ day-to-day lives. Crucially,
normotensive individuals in the study only exhibited a blood pressure
reduction of 3 mmHg systolic and 1.9 mmHg diastolic, suggesting that there
may be a floor effect to reductions of blood pressure seen during fasting in
normotensive individuals. However, a 24 hour fast does appear to be
sufficient to elicit beneficial blood pressure reductions.
In conclusion, an acute 24-hour fast reduces blood pressure and heart
rate in young, healthy, normotensive individuals. Fasting does not influence
blood pressure dipping or sleep blood pressure. Acute fasting may be a
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useful non-pharmacological intervention for those seeking to reduce their
blood pressure.
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6 THE INFLUENCE OF AN ACUTE FAST ON NEURAL
AND CARDIOVASCULAR CONTROL AT REST
6.1 Introduction
The autonomic nervous system plays a key role in the regulation of
blood pressure and is a primary contributor to cardiovascular homeostasis in
humans. Chronic intermittent fasting has been reported to improve multiple
indicators of cardiovascular health. Intermittent fasting reduces systemic
inflammation, oxidative stress, blood pressure, and resting heart rate (de
Cabo & Mattson, 2019). Additionally, routine periodic fasting (1 day per
month) has been associated with lower prevalence of coronary artery disease
(Horne et al., 2008). However, few studies have investigated how fasting
influences the autonomic nervous system and thus the mechanisms behind
the beneficial cardiovascular outcomes reported from intermittent fasting are
unknown.
An overwhelming majority of studies investigating the influence of
fasting on autonomic control have used spectral analysis of heart rate
variability. Short 12 hour fasts increase vagal activity (Kuwahara et al., 2011;
Ohara et al., 2015) and longer periods of food deprivation ≥24 hours
decrease vagal modulation of the heart (S. J. Brown et al., 2012; Mazurak et
al., 2013). The only study that has utilized muscle sympathetic nerve activity
to date is from Andersson et al., who measured MSNA after a 48-hour fast.
While the study reported a slight increase in sympathetic nerve activity, the
sample population were obese women, aged 46-62, and MSNA was only
recorded in 6 participants (Andersson et al., 1988). How a 24-hour fast
influences peripheral neural activity in young, healthy individuals remains
unknown. Multiple studies have demonstrated that 48-hours of fasting
reduces arterial pressure in lean and obese populations (Andersson et al.,
1988; Solianik, Sujeta, Terentjeviene, & Skurvydas, 2016). However, the
mechanism behind the observed reductions in blood pressure are unknown.
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Additionally, 48-hours of complete caloric cessation is not typical for
intermittent fasting that typically utilize 18-24-hour caloric cessation time
periods (Anton et al., 2018; de Cabo & Mattson, 2019; Varady & Hellerstein,
2007).
The purpose of this aim is to assess how 24-hours of fasting influences
hemodynamics, peripheral efferent nerve traffic, and cardiovascular control at
rest. To assess how fasting influences the arterial baroreflex, secondary
analyses will be conducted on spontaneous cardiovagal baroreflex sensitivity.
Additionally, dynamic baroreflex responses will be assessed by correlating
changes in arterial pressure and R-R interval during the Valsalva maneuver.

6.2 Methods
6.2.1 Experimental Design
After blood and urine samples were collected participants laid supine on
a laboratory table. The participants were then instrumented with an ECG,
finger photoplethysmography, microneurography, venous occlusion
plethysmography and a pneumobelt. After stable hemodynamic and
microneurographic signals were established, participants were asked to
breath in time to a computer display set at 15 breaths per minute (0.25 Hz) for
10 minutes (figure below). After the 10 minutes of controlled breathing,
participants were asked to perform 3 Valsalva maneuvers. During each
Valsalva maneuver participants forcefully exhaled to 40 mmHg for 15
seconds into a modified pressure manometer. Each of the 3 Valsalva
maneuvers was separated by a 1-min recovery with normal uncontrolled
breathing. A nose clip was used to seal the nose and a small leak was
allowed in the manometer to keep the glottis open during each strain.
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6.2.2 Data Analysis
Data were sampled at 500 Hz (WINDAQ, Dataq Instruments, Akron OH)
and analyzed with specialized software (WINCPRS, Absolute Aliens, Turku
Finland). R-waves measured from the ECG were automatically detected,
visually inspected, and marked. Systolic and diastolic blood pressures were
marked from the Finometer tracings. Muscle sympathetic nerve burst were
automatically detected and manually verified based on their amplitude and a
1.3 second expected burst peak latency from the previous R-wave. Data were
averaged from the last 8 minutes of the 10 min controlled breathing time.
Heart rate variability was assessed in the frequency domain from R-R
interval spectral power. To obtain power spectrums, the last 8-minutes of
controlled breathing were fast Fourier transformed with a Hanning window.
The high frequency (0.15-0.40 Hz) and low frequency (0.04-0.15 Hz)
components were then normalized to total power (ex. HF/Total power). Using
the arterial pressure waveform as an input stroke volume was automatically
estimated on a beat-to-beat basis using the pulse contour method (Jansen &
Lipsitz, 1995). Forearm blood flow was measured using the limb occlusion
plethysmography method described in section 3.1.1.2.
Spontaneous cardiovagal baroreflex was calculated using the method
explained in section 3.1.1.3. To calculate dynamic baroreflex sensitivity to the
Valsalva maneuver the slope method was utilized. Dynamic baroreflex
sensitivity was determined by the linear relationship of SAP and RRI during
the hypotensive phase II and hypertensive phase IV of the Valsalva
maneuver. To be considered a valid sequence, correlation coefficients were
set at >0.70, and only Valsalva maneuvers that demonstrated morphological
and temporal consistency were included in the analysis. Additionally, a
minimum reduction of 15 mmHg during phase II was required for inclusion.
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6.2.3 Statistical Analysis
All data were analyzed statistically using the commercial software
Sigmaplot 14.0 and Prism GraghPad. Dependent variables of interest were
assessed using a paired t-test. Normality was assessed using a Shapiro-Wilk
test. If the data failed the Shapiro-Wilk normality test a non-parametric
Wilcoxon signed-rank test was used to assess the dependent variables.

6.3 Results
6.3.1 Influence of Fasting on Vagal Modulation and
Hemodynamics
Fasting increased R-R interval and heart rate variability measured via spectral
analysis. The increase in R-R interval paired with the increase in high
frequency power suggests that fasting enhances cardiac vagal tone. A
representative power spectral density is shown for a subject in the fed and
fasted condition is displayed in figure 7. The fasted condition demonstrates a
Figure 7: Spectral Power Fed vs. Fasted Representative Subject

Raw spectral power density for one subject during controlled breathing at
0.25 Hz in both the fed (top) and fasted (bottom) condition)
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quiescence of spectral power in the low frequency range (0.04-0.15Hz) and
an obvious increase in power in the high frequency range (0.15-0.40 Hz).
Blood pressure was similar during controlled breathing between conditions.
Stroke volume and forearm vascular resistance significantly increased in the
fasted condition compared to the fed condition. Muscle sympathetic burst
frequency and burst incidence did not change between the fed and fasted
conditions (N=13; 3F) as shown in Table 8.

Figure 8: Forearm Vascular Resistance and Stroke Volume

Forearm Vascular Resistance (FVR) represented as individual data points and connecting
lines. Stroke volume (MAP) represented as mean with standard error. *p<0.05
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Table 8: Fed vs. Fasted Controlled Breathing Data

Variable

Fed

Fasted

MD

t-test
p-value

R-R Interval, ms

992±30

1059±37*

67±32

.024

SAP, mmHg

107±2.5

107±2.2

0.1±2.5 .481

DAP, mmHg

57±1.9

58±2.0

0.3±1.8 .431

Burst Frequency, b/min

16±3.1

15±2.2

1.6±1.7 .180

Burst Incidence, b/100hb

23±4.4

26±3.8

0.4±2.2 .426

RRI HFnu, A.U.

54.5±2.6

61.8±3.2*

.07±.04 .022

RRI LFnu, A.U.

45.5±2.6

38.2±3.2*

.07±.04 .022

Stroke Volume, mL

88±4.0

100±5.4*

13.7±6

Forearm Blood Flow,
ml*100ml-1*min-1

2.4±.19

2.2±.22

0.2±0.2 .143

Forearm Vascular
Resistance,
mmHg*100mL*min*mL-1

36.9±3.6

46.2±5.9*

9.4±4.3 .019

.017

Values are mean ± SE. Paired t-tests were used to compare variables between the fed and
fasted condition. MD = mean difference between the fed and fasted condition one-tailed pvalues are displayed. (*) = p ≤ 0.05 (**) = p ≤ 0.01

6.3.2 Influence of Fasting on Spontaneous and Dynamic
Cardiovagal Baroreflex Sensitivity
Spontaneous cardiovagal baroreflex sensitivity was enhanced in the
fasted condition. Specifically, cvBRS up-up sequences were significantly
increased and cvBRS down-down sequences exhibited a strong trend to
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increase in the fasted condition. An example of the Valsalva maneuver
phases is depicted in figure 8. Enhanced cardiovagal baroreflex sensitivity
was also measured during Phase IV, or the hypertensive component of the
Valsalva maneuver. Increases in RRI were also augmented during the Phase
IV overshoot in the fasted condition compared to the fed condition. Twentytwo participants were included in the Valsalva analysis. Three participants
were excluded because they had no SAP-RRI correlations above .70.
Average SAP-RRI correlation coefficients for included participants were 0.88
for Phase II and 0.81 for Phase IV.
Figure 9: Influence of Fasting on Baroreflex Sensitivity

Cardiovagal Baroreflex sensitivity up-up (cvBRS up-up) represented as individual data
points and bar graph (mean ± SE). Valsalva phase IV SAP-RRI (VM Phase IV) slope
represented as individual data points and bar graph (mean ± SE) *p<0.05;
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Figure 10: Representative Valsalva Response for One Subject

II

IV
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Table 9: Influence of Fasting on Baroreflex Sensitivity
Variable

Fed

Fasted

MD

t-test
p-value

Wilcoxon
p-value

SP cvBRS upup,
ms/mmHg

20±2.3

26±4.8*

.029

SP cvBRS
down-down,
ms/mmHg

17±1.6

21±2.4

.076

VM cvBRS
Phase II,
ms/mmHg

11±1

12±1.4

.474

VM cvBRS
Phase IV,
ms/mmHg

9±1.0

12±1.2**

2.2±0.9

ΔRRI Phase IV,
ms

414±42.2

484±40.6*

69.7±33.9 .026

.010

Values are mean ± SE. Paired t-tests were used to compare variables between the fed and
fasted condition. SP = Spontaneous VM = Valsalva Maneuver. MD = mean difference
between the fed and fasted condition. One-tailed p-values are displayed. (*) = p ≤ 0.05 (**)
= p ≤ 0.01

6.4 Discussion
We tested young, healthy, normotensive individuals twice, once 24hours postprandial (fasted) and 3-hours postprandial (Fed) separated by a
month. Our purpose was to determine how acute fasting influences
cardiovascular control mechanisms, hemodynamics, and peripheral
sympathetic activity. We report three novel findings. First, acute fasting
increases vagal modulation at the heart without altering peripheral
sympathetic outflow. Second, fasting enhances cardiovagal baroreflex
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sensitivity measured both spontaneously and when baroreceptors are
challenged with a naturally induced hypertensive stimulus. Third, forearm
vascular resistance and stroke volume were increased in the fasted state.
Previous studies have reported mixed results on the influence of acute
fasting on cardiovagal activity. Herbert et al., reported that 24 hours of fasting
reduced the high frequency component of HRV but did not report an increase
in heart rate that would be expected with reduced vagal activity at the heart
(Herbert et al., 2012; Mazurak et al., 2013). Mazurak et al., reported that after
24 hours of fasting participants tended to demonstrate increases in HRV and
RRI that abated after 48 hours of fasting (Mazurak et al., 2013). However,
both these studies were done soley in women and only reported heart rate
varibility and not cardiovagal baroreflex sensitivity. In contrast, our study
provides the following evidence to suggest that acute fasting enhances vagal
modulation of the heart. 1) fasting increases R-R interval; 2) concomitanly,
HFnu is significantly increased and LFnu is decreased; 3) spontanoeous and
dynamic cardiovagal baroreflex sensitvity is increased indicating enhanced
reflexive vagal activation. Additonally, the enhanced cardiovagal baroreflex
sensitvity provides a potenital explanatory mechanism for the overall
reduction in ambulatory blood pressure recorded while particpants were
fasting (chapter 5). Increased cardiovagal baroreflex sensitvity and enhanced
dampening of increases in blood pressure, as measured during the Valsalva,
could effectivly lower average 24-hour arterial pressure. Additonally,
increased RRI indicates a reduction in heart rate in agreeance with the
reduction in 24-hour heart rate measured from the ABPM monitor (chapter 5).
This evidence supports the hypothesis that fasting increases parasympathetic
activity at the heart.
We did not observe a change in peripheral sympathetic outflow between
the fed and fasting condition. At first a lack of change in sympathetic outflow
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is counter-intuitive as previous studies have suggested that MSNA and
cardiac sympathetic markers of HRV change inparallel in response to
autonomic challeneges (DeBeck, Petersen, Jones, & Stickland, 2010; Pagani
et al., 1997) Additonally, MSNA correlates strongly with cardiac
norepinephrine spillover at rest (B.G. Wallin et al., 1992). However, previous
animal studies have reported that fasting induces a disassociation between
symapthetic actvitiy at the heart and sympahetic stimulation of the adrenal
medulla (J. B. Young et al., 1984). Therefore, it is resonable to speculate that
in the fasted state, parasympathetically mediated cardiovascular control is
enhanced and peripheral sympathetic outflow is unaffected and/or
disassociated from cardiovascular oscilations.
Lastly, fasting reduces overall 24-hour blood pressure (Chapter 5) but
a reduction in blood pressure was not observed acutly during the autonomic
function test. Blood pressure between the conditions was similar during the
autonomic test despite a measured reduction in heart rate in the fasted
condition. Two separate measures explain how blood pressure is maintained
in the fasted condition even with reduction in heart rate and no change in
MSNA; 1) forearm vascular resistance is increased in the fasted condition;
and 2) stroke volume is increased in the fasted condition. This study does not
have a measured mechanism to explain the descriptive increases in vascular
resistance or stroke volume. However, previous studies have measured that
after 24 hours of fasting urine norepineprine increases (Chan, Mietus, Raciti,
Goldberger, & Mantzoros, 2007) and as fasting time prolongs (48-72 hours)
blood epinephrine, norepineprine, and cortisol increase (Boyle, Shah, &
Cryer, 1989). We did not measure blood catecholamines but it is possible that
after 24-hours of fasting circulating epinephrine and norepinephrine were
elevated increasing peripheral vascular resistance and cardiac inotropy.
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In conclusion, acute fasting increases vagal modulation of the heart and
enhances cardiovagal baroreflex sensitivity. Increased baroreflex sensitivity
and vagal modulation of the heart suggest that fasting may convey acute
cardioprotective benefits. Additonally, enhanced baroerflex sensitivty
potentially explains the reductions in 24-hour blood pressure reported in
chapter 5. Heart rate was reduced in the fasted condition but blood pressure
was similar during the autonomic test between conditions. The reduction in
heart rate seems to have been compenstated by increased peripheral
resistance and stroke volume. However, the creation of peripheral resistance
is not from increased peripheral sympahetic activation and is beyond the
scope of this study to discuss. Collectivly, the AMPB data from chapter 5 and
these data support the idea that acute fasting may be an effective dietary
intervention for lowering blood pressure and improving cardiovascular health.
Nevertheless, future chronic studies are warrarented to eclucidate whether
the cardiovascular benefits of fasting are sustained in the long term.
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7 THE INFLUENCE OF AN ACUTE FAST ON NEURAL AND
CARDIOVASCULAR REACTIVITY TO MENTAL STRESS

7.1 Introduction
Mental stress is associated with the development of myocardial
ischemia and hypertension (Deanfield et al., 1984; Yan et al., 2003). There is
evidence suggesting that short-term fasting can alter adrenocortical
responses to a mental stressor (Kirschbaum et al., 1997). Short-term fasting
(8-10 hours) can blunt cortisol release following a mental stressor in healthy
young men (Kirschbaum et al., 1997). Additionally, short-term fasting (12
hours) influences splanchnic vascular responses to a mental stress (mental
arithmetic). Performing a mental task while fasted induces vasoconstriction in
the superior mesenteric artery, a response not exhibited under post-prandial
conditions (Someya, Endo, Fukuba, Hirooka, & Hayashi, 2010).
Vasoconstriction of the superior mesenteric artery suggests fasting alters
vascular responses to mental stress to visceral organs and thus could
modulate cardiac output and arterial pressure. A common experimental
mental stressor is mental arithmetic. During mental arithmetic participants
repeatedly subtract the number six or seven from a two- or three-digit
number. This type of mental stress produces reproducible reactivity in mean
arterial pressure, heart rate, and muscle sympathetic nerve activity across
laboratory sessions (Fonkoue & Carter, 2015). The purpose of this aim is to
investigate if fasting influences neural and vascular responsiveness to mental
stress. We tested the hypothesis that fasting will reduce the cardiovascular
and neural reactivity to mental stress.

7.2 Methods
7.2.1 Experimental Design
After the controlled breathing protocol three brachial blood pressures
were taken and the NOVA Finometer was recalibrated to the averaged
brachial pressure. Participants were then asked to rest quietly for 5 minutes,
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and a second baseline was recorded. After the 5-minute baseline participants
performed 5 minutes of mental stress via mental arithmetic. The mental
arithmetic involved continuous and rapid subtraction of the number 6 or 7
from a two- or three-digit number. Participants were encouraged by
investigators to answer as quickly and as accurately as possible. Participants
answered verbally and were corrected if they answered incorrectly. ECG,
beat-to-beat blood pressure, muscle sympathetic nerve activity, and forearm
blood flow were recorded at rest and during the mental stress task. After the
mental stress task participants were asked to rate their perceived stress using
a five-point scale. 0, not stressful; 1 somewhat stressful; 2, stressful; 3, very
stressful; and 4, very, very stressful.

7.2.2 Data Analysis
All data were analyzed statistically using the commercial software
Sigmaplot 14. The stress reactivity was calculated as the mean stress
response to each min of mental stress minus the 5-min mean baseline. The
minute-by-minute reactivity to mental stress was analyzed using a 2-way
repeated measures ANOVA (Condition X Time). Data are presented as
means ± SE. A probability value of ≤ 0.05 was considered statistically
significant.

7.3 Results
7.3.1 Cardiovascular Reactivity to Mental Stress
During mental stress minute by minute changes (Δ) in HR, SAP, DAP,
and MAP were remarkably comparable between fed and fasted condition. No
condition by time effect was detected for any of the primary outcome
variables. Additionally, perceived stress during mental arithmetic was similar
between the fed and fasted condition (Fed vs. Fasted; 2.2±0.2 vs 2.3±0.2;
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p=.737). Additionally, forearm blood flow and forearm vascular resistance was
not altered between condition (N=14).
Figure 11: Mean Arterial Pressure and Heart Rate Responses to Mental Stress

Line graphs are minute by minute mean changes (Δ) in heart rate (HR) and mean arterial
pressure (MAP). Bar graphs display mean ± SE changes in HR and MAP during 5 min of
mental stress for both the fed and fasted condition.
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Figure 12: Forearm Blood Flow Responses to Mental Stress

Bar graphs display percentage changes (Δ) form baseline in forearm blood flow (FBF)
and forearm vascular resistance (FVR) during 5 min of mental stress for both the fed and
fasted condition.

7.3.2 Neural Reactivity to Mental Stress
Burst frequency and MSNA total activity did not change between
conditions at baseline or upon exposure to mental stress (N=12).
Figure 13: Muscle Sympathetic Activity Responses to Mental Stress

Bar graphs display changes (Δ) form baseline in burst frequency and MSNA total Activity
during 5 min of mental stress for both the fed and fasted condition.

94

7.4 Discussion
This study is the first to investigate the influence of fasting on neural and
cardiovascular reactivity to mental stress. In contrast to our hypothesis,
fasting did not reduce neural or cardiovascular responses to a mental stress
challenge. Changes in heart rate, blood pressure, forearm blood flow, and
muscle sympathetic nerve activity were remarkably similar during a mental
stress challenge between the fed and fasted condition, suggesting that the
pressor response to mental stress and mechanisms that drive it are
unaffected by a short-term negative energy balance.
Short-term fasting has been reported to increase irritability and
psychological stress for some individuals (Watkins & Serpell, 2016). Our
study demonstrates that fasting does not appear to act as a compounding
stressor and does not increase the severity of the pressor response upon
exposure to a mental stress. This is important to consider as greater
cardiovascular responses to mental stress are associated with greater
cardiovascular risk (Chida & Steptoe, 2010). Perceived stress measured after
the mental stress task did not differ between the fed and fasted condition.
Callister et al., reported that during a cognitive challenge perceived stress is
an important determinant of the MSNA response (Callister, Suwarno, & Seals,
1992). Thus, the consistency in perceived stress between conditions could
potentially influence the observed similarities in MSNA reactivity. However,
more recent studies by Carter et al., have not found an association between
perceived stress and MSNA reactivity (Carter, Durocher, & Kern, 2008; Carter
& Ray, 2009).
Reactivity to mental stress is highly reproducible. MAP, HR, and MSNA
reactivity to mental stress are reproducible within a study and across
laboratory visits (Fonkoue & Carter, 2015) In addition, altering neural and
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cardiovascular responses to mental stress within an individual is difficult.
Aerobic exercise training for 8-weeks and even a 12-week weight loss
program (5% loss of weight) do not alter neural or hemodynamic reactivity to
mental stress (Ray & Carter, 2010; Torres & Nowson, 2007). A study in obese
women found that weight loss acquired through the combination of diet and
exercise reduces MSNA reactivity to mental stress (Tonacio et al., 2006).
Even total sleep deprivation does not alter blood pressure of MSNA reactivity
to mental stress, although sleep deprivation does increase heart rate
reactivity (Yang, Durocher, Larson, Dellavalla, & Carter, 2012). Our measured
cardiovascular and neural reactivity to mental stress are similar to other
studies that have utilized mental arithmetic (Carter & Goldstein, 2015).
In conclusion, fasting does not alter cardiovascular or neural reactivity to
mental stress or influence forearm blood flow reactivity to mental stress.
Fasting does not act as a compounding stressor as perceived stress after
mental arithmetic is also not augmented by fasting. This study provides
insight into human cardiovascular reactivity to a mental stressor while in a
negative energy balance.
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8 THE INFLUENCE OF AN ACUTE FAST ON NEURAL
AND CARDIOVASCULAR RESPONSES TO LOWER
BODY NEGATIVE PRESSURE
8.1 Introduction
Tilt-table studies have demonstrated that participants who have fasted
for 24, 48, and 72 hours exhibit greater vagal withdrawal when exposed to tilt
compared to the fed state (S. J. Brown et al., 2012; Mazurak et al., 2013).
Reduced parasympathetic activity at the heart during tilt suggests greater
sympatho-excitation in response to an orthostatic challenge. The only lower
body negative pressure (LBNP) study conducted in fasted humans was
performed by Bennet et al. In their study they exposed 9 male participants to
progressive LBNP of negative 10, 20, 30, 40 and 50 mmHg for periods of 1
min separated by 1 min rest. They compared 12-hours of fasting to 48-hours
of fasting. After 48-hours of fasting systolic pressure decreased during LBNP
and heart rate had increased to a greater extent when compared to the fed
state (Bennett, MacDonald, & Sainsbury, 1984). 48-hours of fasting also
increased forearm blood flow in Bennet’s sample population at rest and
impaired vasoconstriction during LBNP (Bennett et al., 1984). The tilt-table
studies and LBNP study seem to provide converging evidence suggesting
that fasting reduces tolerance to an orthostatic challenge. However, direct
evidence of a reduced tolerance to an orthostatic challenge has not been
established. This is important because while LBNP not only presents an
orthostatic challenge it is also an effective simulation of hemorrhage (W. H.
Cooke et al., 2004). Fulfillment of specific aim 3 could provide valuable
information regarding the relationship between fasting and tolerance to
hemorrhage that has application for preoperative fasting as well as military
medicine. Therefore, the purpose of this study was to determine how fasting
for 24 hours influences orthostatic tolerance to intense LBNP. Specifically, we
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tested the hypothesis that acute fasting reduces orthostatic tolerance to
intense LBNP

8.2 Methods
8.2.1 Experimental Design
After the mental stress protocol, a three-minute recovery period, and ten
minutes of non-recorded rest time, three brachial blood pressures were taken
and the NOVA Finometer recalibrated to the averaged brachial pressure. An
airtight seal was then secured around participants’ waists at the level of the
iliac crest. Participants were then asked to rest quietly for 5 minutes and a
third baseline was recorded. Following the 5-minute baseline lower body
negative pressure was progressively applied in a stepwise manner. Lower
body negative pressure was increased every 5 minutes in increments of 15
until – 60 mmHg (ex: -15, -30, -45, -60). After -60 mmHg LBNP was increased
in increments of 10 mmHg until onset of pre-syncope or until voluntary
participant termination of LBNP. Termination criteria for presyncope were; 1)
a drop in systolic pressure of 15 mmHg or greater for 10 seconds or greater;
2) sudden bradycardia; and/or 3) participant-initiated termination. The
chamber pressure was released immediately at the onset of presyncope or
upon participant-initiated termination of LBNP.

8.2.2 Data Analysis
Tolerance to LBNP was assessed by total duration of negative pressure
(DNP) in seconds and the cumulative stress index (CSI; pressure X time).
ECG, beat-to-beat blood pressure, muscle sympathetic nerve activity, and
forearm blood flow were measured continuously throughout the protocol. Data
were averaged by taking the last 3 minutes of every 5-minute pressure stage.
The last minute just prior to presyncope was also averaged for consistency
despite variable termination times. Due to individual and conditional variability
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in time to presyncope, we normalized time to presyncope for comparison
between participants (appendix A.4). Quantifying percent to presyncope as 0,
40, 80, and 100% for each participant. Using this approach every participant
is represented within the percentages to presyncope. A paired t-test was used
to assess duration of negative pressure, cumulative stress index, and overall
changes in forearm vascular resistance. A 2-way repeated measures ANOVA
(% to presyncope by Condition) was used to assess primary outcome
variables. Data are presented as means ± SE. A probability value of ≤ 0.05
was considered statistically significant.

8.3 Results
8.3.1 Fasting and Lower Body Negative Pressure Tolerance
Figure 14: Tolerance to Lower Body Negative Pressure

Duration of negative pressure and cumulative stress index represented as boxplots. The
line in the boxplots represents the median and the box represents the interquartile range
(IQR; the difference between the 25th and 75th percentile). The whiskers extend from the
upper and lower edge of the box to the highest and lowest values. *p<0.05

Fasting moderately reduced tolerance to the orthostatic stress of LBNP.
Duration of negative pressure was significantly reduced in the fasted
condition and cumulative stress index tended to be lower in the fasted
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condition. Only participants for which the investigator-initiated termination of
LBNP were included in this data set (N=18).

8.3.2 Hemodynamic and Neural Responses to Presyncopal
LBNP
During LBNP, heart rate increased similarly in both conditions. Systolic
blood pressure was maintained in both conditions up until presyncope. An
example of a presyncopal drop in blood pressure and concomitant MSNA
activity can be seen in figure 17. Maintaining stable nerve recordings
throughout LBNP was difficult and was only measured in 7 participants.
However, while there was no significant condition by percent to presyncope
interaction, the fasted group was slower to ramp up nerve activity. The fasted
condition significantly increased burst frequency starting at the 80% to
Figure 15: Forearm Vascular Resistance During Lower Body Negative Pressure

Line graph is mean ± SE changes in forearm vascular resistance (FVR) for a given
percent to presyncope for both the fed and fasted condition. Bar graphs display
percentage (mean ± SE) change in FVR from baseline to 100% presyncope for both the
fed and fasted condition
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presyncope time point. This is in contrast to the fed condition which
significantly increased burst frequency from baseline at 40% to presyncope.
Stroke volume and forearm blood flow decreased similarly between the
conditions. The fed condition continuously increased calculated total
peripheral resistance as LBNP increased. In contrast the fasted condition did
not significantly increase calculated TPR during the LBNP protocol.
Concurrently, while forearm vascular resistance increased in both condition
when compared to baseline, only the fed condition significantly increased
FVR at each time point. Additionally, percent change in FVR from baseline to
presyncope was greater in the fed condition compared to the fasted condition.
Figure 16: Muscle Sympathetic Nerve Activity During Lower Body Negative Pressure

Line graph is mean±SE changes in muscle sympathetic nerve activity (MSNA; N
= 7) for a given percent to presyncope for both the fed and fasted condition.
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Table 10: Percent to Presyncope LBNP Data

Fed

0

40%

80%

100%

%

Cond X
%

Heart Rate, beat per
minute

63±1

65±1

85±1*

96±1*

<.01

.86

SAP, mmHg

115±1

116±1

114±1

110±1*

.01

.61

Burst Frequency, b/min
(N=7)

15±1

25±1*

41±1*

43±1*

<.01

.08

Stroke Volume, mL

84±2

74±2*

55±2*

51±2*

<.01

<.01

TPR

17±1

19±1*

20±1*

21±1*

<.01

.41

Forearm Blood Flow,
ml*100ml-1*min-1

2.4±.1

1.7±.1*

1.5±.1*

1.2±.1*

<.01

<.01

Forearm Vascular
Resistance,
mmHg*100mL*min*mL-1

35±3

61±3*

73±3*

85±3*

<.01

<.01

Fasted

0

40%

80%

100%

Heart Rate, beat per
minute

59±1

61±1

80±1*

94±1*

SAP, mmHg

113±1

114±1

114±1

105±1*

Burst Frequency, b/min
(N=7)

15±1

21±1

38±1*

45±1*

Stroke Volume, mL

96±2Ϯ

83±2*

57±2*

50±2*

TPR

17±1

18±1

20±1

17±1

Forearm Blood Flow,
ml*100ml-1*min-1

2.1±.1

1.7±.1*

1.6±.1*

1.5±.1*

Forearm Vascular
Resistance,
mmHg*100mL*min*mL-1

42±3

56±4*

64±4*

63±4*

Values are mean ± SE. A 2-way repeated measures ANOVA was used to compare variables (% to presyncope X
Condition). Fisher LSD post-hoc test was used to compare variables that had a significant percent to presyncope
(%) or condition interaction (*) = significant differences within a condition from baseline (†) = significant difference
between % X condition
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Figure 17: Blood Pressure and MSNA at Presyncope in a Representative
Subject

8.4 Discussion
Trauma is a leading cause of death worldwide and approximately half of
the deaths can be attributed to hemorrhage. In both civilian and military
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patients, hemorrhage is the primary cause of death within the first hour of
traumatic injury. LBNP is an effective simulation of the central hypovolemia
that occurs during hemorrhagic shock (William H. Cooke, Rickards, Ryan,
Kuusela, & Convertino, 2009; William H Cooke, Kathy L Ryan, & Victor A
Convertino, 2004). The purpose of this study was to investigate if fasting
affected tolerance to a severe orthostatic stress. This study has two novel
findings. First, acute fasting reduces participants orthostatic tolerance. The
amount of time participants could tolerate negative pressure was reduced in
the fasted state by approximately 10%. Additionally, the calculated cumulative
stress index tended to be lower in the fasted condition. Second, the cause for
the decrease in orthostatic tolerance appears to be an impaired ability to
increase peripheral resistance.
In the fasted condition, forearm vascular resistance plateaus at 80% of
presyncope and does not increase any further at presyncope. Furthermore,
the total change in forearm vascular resistance from baseline to presyncope
is significantly lower in the fasted condition compared to the fed condition.
Concurrently, calculated peripheral resistance did not change in the fasted
condition. These two separate estimates of peripheral resistance indicate that
fasting impairs increases of vascular resistance to reduce tolerance to central
hypovolemia. Heart rate and arterial pressure were similar between
conditions when exposed to LBNP. MSNA data are limited, as maintaining a
stable nerve signal for both conditions throughout LBNP is difficult. However,
the fasted condition exhibited a slower increase in MSNA. In the fasted
condition MSNA did not significantly increase from baseline until 80% to
presyncope. In contrast, MSNA increased significantly in the fed condition at
40% to presyncope. Enhanced stroke volume in the fasted condition may
account for this slower ramp in muscle sympathetic nerve activity. Higher
intensity LBNP may be needed to overcome the enhanced stroke volume in
the fasted condition to unload the baroreceptors and initiate vasoconstriction
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via MSNA. Impaired vascular resistance has been reported before during
LBNP after 48 hours of fasting (Bennett et al., 1984). However, the study by
Bennet et al. was limited in its scope as exposure to LBNP was brief (1 min
per stage) and did not test tolerance (max pressure -50 mmHg). Our study is
the first to report that fasting in humans reduces tolerance to induced central
hypovolemia and that this reduction in tolerance is likely caused by impaired
vascular resistance.
Our results have clinical implications in regard to preoperative fasting. A
recent study reported that hemorrhage is the leading cause of death post
non-cardiac surgery (15.6%) (Spence et al., 2019). A majority of the postsurgery deaths occurred shortly after operating during the post-surgery stay.
To mitigate the risk of aspiration, the American Society of Anesthesiologists
recommends cessation of clear liquids 2 hours before surgery and solid food
6-8 hours before surgery ("Practice Guidelines for Preoperative Fasting and
the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary
Aspiration: Application to Healthy Patients Undergoing Elective Procedures:
An Updated Report by the American Society of Anesthesiologists Task Force
on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the
Risk of Pulmonary Aspiration*," 2017). However, due to the unpredictable
nature of operating rooms fasting is typically prolonged up to 14 hours (Chon,
Ma, & Mun-Price, 2017) and can even extend to 1 or 2 days (Diks et al.,
2005). Animal studies have reported that 24 hours of fasting reduces the
survival rate of hemorrhage (Ljungqvist, Jansson, & Ware, 1987). In rats
subjected to hemorrhagic hypotension, all postprandial rats survived, and all
rats deprived of food for 24 hours died. Saline infusion did not increase
survival in the food deprived rats (Ljungqvist et al., 1987). Our study suggests
that extended fasting (≥24 hours) may reduce humans’ ability to tolerate
central hypovolemia by approximately 10%. Although fasting moderately
reduced tolerance to central hypovolemia, preoperative fasting duration may
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be an important risk factor for physicians to consider in mitigating the risk of
hemorrhagic shock.
In conclusion, fasting (24 hours postprandial) reduced participants
tolerance to a severe orthostatic stress likely by blunting the increases of
vascular resistance. An impaired peripheral vascular resistance response in
the fasted state was measured by both venous occlusion plethysmography
and by calculated total peripheral resistance. Further studies are warranted to
understand the mechanisms underlying the reduced tolerance to central
hypovolemia while fasted.
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9 CONCLUSIONS AND FUTURE DIRECTIONS
9.1 Conclusion
Obesity is a major risk factor for the development of cardiovascular
disease (Poirier et al., 2006). Contemporary humans’ intake more and expend
less energy than their ancestors. This energy imbalance has contributed to an
alarming increase in prevalence of obesity in the United States (31% 2000 vs.
42% 2020) (Hales et al., 2020). Accessible and effective countermeasures
are needed to abate the rise and obesity and improve cardiovascular health
outcomes. Evidence suggests that chronic intermittent fasting can help
individuals lose weight, reduce blood pressure, and improve cardiometabolic
health (Stekovic et al., 2019; Varady et al., 2013). However, the mechanism
behind these reported reductions in arterial pressure caused by chronic
intermittent fasting has not been elucidated in humans. Therefore, the
purpose of this dissertation was to investigate how acute fasting influences
autonomic cardiovascular control of arterial pressure at rest and during
stress.
This dissertation employed continuous 24-hour hemodynamic
recordings while participants were fasted and fed to ascertain how acute food
deprivation influences arterial pressure. Additionally, this dissertation utilized
an autonomic battery to investigate how fasting influences the balance
between the sympathetic and parasympathetic branches. The balance
between the autonomic branches was investigated using indirect measures of
autonomic activity at the heart and direct peripheral sympathetic neural
recordings to vascular beds. Aim 1 of this dissertation was to determine the
influences of an acute fast on hemodynamics, sympathetic neural activity,
and cardiovascular control at rest. Aim 2 employed a mental arithmetic task
to investigate how fasting influences neural and cardiovascular reactivity to a
mental stressor. Aim 3 investigated how an acute fast influenced tolerance
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and cardiovascular reactivity to central hypovolemia. Broadly speaking, the
scientific rationale for Aim 1 was to elucidate if acute fasting conveyed any
acute cardiovascular benefit and to elucidate the potential mechanisms
behind the observed cardiometabolic benefits of chronic fasting. The scientific
rationale behind Aim 2 was to determine if acute fasting altered
cardiovascular or neural reactivity to a mental stress task. Lastly, the rationale
for Aim 3 was to assess if fasting reduced tolerance to induced central
hypovolemia. Aim 3 is of clinically relevant as fasting is a common practice
for those undergoing surgical procedures and hemorrhage is a serious risk
during and after surgery.
From Aim 1 we were able to demonstrate that acute fasting may convey
cardioprotective benefits through enhanced vagal tone and reduced 24-hour
blood pressure. Specifically, acute fasting increased heart rate variability and
enhances cardiovagal baroreflex sensitivity at rest and during a naturally
induced hypertensive stimulus. Improved cardiovagal baroreflex sensitivity
potentially explains the measured reduction in overall 24-hour blood pressure.
We did not measure any change in peripheral sympathetic activity indicating
that fasting primary influences sympathetic modulation at the level of the
heart. This aim provides mechanistic evidence to support the known
cardiovascular benefits of chronic intermittent fasting.
Aim 2 demonstrated that fasting does not affect cardiovascular or neural
reactivity to a mental stress task. Indicating that an acute fast does alter or act
as a compounding stressor during a mental stress task. From Aim 3 we
report evidence to suggest that fasting reduces tolerance to a severe
orthostatic stress by potentially reducing the ability to increase vascular
resistance in the periphery. Additionally, Aim 3 provides marginal evidence
from neural recordings that sympathetic burst frequency is not the cause of
this augmented peripheral resistance.
108

This dissertation provides several novel findings that contribute
mechanistic and descriptive insights into how systemic energy balance
influence the autonomic nervous systems control of arterial pressure at rest
and during stress. Acute fasting appears to convey cardioprotective benefits
by reducing blood pressure, increasing heart rate variability, and enhancing
baroreflex sensitivity. However, the cardioprotective benefits of fasting should
be balanced with the reduction in orthostatic tolerance. The reduction in
orthostatic tolerance suggests that individuals who decide to acutely fast
should do so if they are 1) not susceptible to postural orthostatic intolerance
2) not at risk for severe hemorrhage.

9.2 Future Directions
This dissertation provides evidence that suggests that acute fasting
reduces blood pressure, increases vagal modulation of the heart, and
enhances baroreflex sensitivity. However, the temporal range of these
cardiovascular benefits when energy consumption resumes is unknown.
Additionally, the sample population for this study was young, healthy,
normotensive, normal weight individuals. Future studies should expand into
populations of clinical interest, such as individuals with hypertension.
Studying fasting in individuals with hypertension would provide valuable
information regarding fasting as a viable intervention to decrease blood
pressure and enhance baroreflex sensitivity in these individuals.
In animals, it is well established that food deprivation decreases survival
to hemorrhagic hypotension (Ljungqvist et al., 1987). In rats, two separate
studies have reported that food deprivation (20-24 hours) results in 100%
mortality to hemorrhagic hypotension, compared to a 100% survival rate in
the postprandial rats (DARLINGTON, NEVES, HA, CHEW, & DALLMAN,
1990; Ljungqvist et al., 1987) However, when food deprived (24 hours) rats
are infused with glucose just prior to standardized hemorrhage all survive
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(Alibegovic & Ljungqvist, 1993). The glucose infused rats were compared to
food deprived rats that were given a saline infusion of equal volume. This
study in animals provides evidence to suggest that glucose infusion just prior
to simulated central hypovolemia in fasted humans may potentially increase
their orthostatic tolerance. Future studies should employ oral or infused
glucose to investigate if a rapid energy infusion could increase tolerance to
central hypovolemia in fasted participants. Such a study could provide
insightful knowledge to physicians wanting to mitigate the risk of hemorrhagic
shock during and after surgery.

110

REFERENCES
Acheson, K., Jéquier, E., & Wahren, J. (1983). Influence of beta-adrenergic
blockade on glucose-induced thermogenesis in man. J Clin Invest,
72(3), 981-986. doi:10.1172/jci111070
Acheson, K. J., Ravussin, E., Wahren, J., & Jéquier, E. (1984). Thermic effect
of glucose in man. Obligatory and facultative thermogenesis. J Clin
Invest, 74(5), 1572-1580. doi:10.1172/jci111573
Ackerknecht, E. H. (1974). The history of the discovery of the vegatative
(autonomic) nervous system. Medical history, 18(1), 1-8.
Agoston, D. V. (2017). How to Translate Time? The Temporal Aspect of
Human and Rodent Biology. Frontiers in neurology, 8, 92-92.
doi:10.3389/fneur.2017.00092
Ali, Y. S., Daamen, N., Jacob, G., Jordan, J., Shannon, J. R., Biaggioni, I., &
Robertson, D. (2000). Orthostatic intolerance: a disorder of young
women. Obstetrical & gynecological survey, 55(4), 251-259.
Alibegovic, A., & Ljungqvist, O. (1993). Pretreatment with glucose infusion
prevents fatal outcome after hemorrhage in food deprived rats.
Circulatory shock, 39(1), 1-6. Retrieved from
http://europepmc.org/abstract/MED/8481972
Andersson, B., Wallin, G., Hedner, T., Ahlberg, A. C., & Andersson, O. K.
(1988). Acute effects of short-term fasting on blood pressure,
circulating noradrenaline and efferent sympathetic nerve activity. Acta
Med Scand, 223(6), 485-490. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/3389203
Anton, S. D., Moehl, K., Donahoo, W. T., Marosi, K., Lee, S. A., Mainous, A.
G., 3rd, . . . Mattson, M. P. (2018). Flipping the Metabolic Switch:
Understanding and Applying the Health Benefits of Fasting. Obesity
(Silver Spring), 26(2), 254-268. doi:10.1002/oby.22065
Ariyasu, H., Takaya, K., Tagami, T., Ogawa, Y., Hosoda, K., Akamizu, T., . . .
Nakao, K. (2001). Stomach Is a Major Source of Circulating Ghrelin,
and Feeding State Determines Plasma Ghrelin-Like Immunoreactivity
Levels in Humans. The Journal of Clinical Endocrinology &
Metabolism, 86(10), 4753-4758. doi:10.1210/jcem.86.10.7885
Aronow, W. S., & Ahn, C. (1997). Association of postprandial hypotension
with incidence of falls, syncope, coronary events, stroke, and total
mortality at 29-month follow-up in 499 older nursing home residents. J
Am Geriatr Soc, 45(9), 1051-1053. doi:10.1111/j.15325415.1997.tb05965.x
Astrup, A., Simonsen, L., Bulow, J., Madsen, J., & Christensen, N. J. (1989).
Epinephrine mediates facultative carbohydrate-induced thermogenesis
in human skeletal muscle. American Journal of Physiology111

Endocrinology and Metabolism, 257(3), E340-E345.
doi:10.1152/ajpendo.1989.257.3.E340
Benjamin, N., Calver, A., Collier, J., Robinson, B., Vallance, P., & Webb, D.
(1995). Measuring Forearm Blood Flow and Interpreting the
Responses to Drugs and Mediators. Hypertension, 25(5), 918-923.
doi:doi:10.1161/01.HYP.25.5.918
Bennett, T., MacDonald, I. A., & Sainsbury, R. (1984). The Influence of Acute
Starvation on the Cardiovascular Responses to Lower Body
Subatmospheric Pressure or to Standing in Man. Clinical Science,
66(2), 141-146. doi:10.1042/cs0660141
Berne, C., Fagius, J., & Niklasson, F. (1989). Sympathetic response to oral
carbohydrate administration. Evidence from microelectrode nerve
recordings. J Clin Invest, 84(5), 1403-1409. doi:10.1172/jci114313
Blaber, A., Yamamoto, Y., & Hughson, R. (1995). Methodology of
spontaneous baroreflex relationship assessed by surrogate data
analysis. Am. J. Physiol, 268, H1682-H1687.
Blackwell, D. L., & Clarke, T. C. (2018). State variation in meeting the 2008
federal guidelines for both aerobic and muscle-strengthening activities
through leisure-time physical activity among adults aged 18-64: United
States, 2010-2015. National health statistics reports(112), 1-22.
Boden, G., Chen, X., Mozzoli, M., & Ryan, I. (1996). Effect of fasting on
serum leptin in normal human subjects. The Journal of Clinical
Endocrinology & Metabolism, 81(9), 3419-3423.
Boyle, P. J., Shah, S. D., & Cryer, P. E. (1989). Insulin, glucagon, and
catecholamines in prevention of hypoglycemia during fasting.
American Journal of Physiology-Endocrinology and Metabolism,
256(5), E651-E661. doi:10.1152/ajpendo.1989.256.5.E651
Brodde, O.-E., Bruck, H., Leineweber, K., & Seyfarth, T. (2001). Presence,
distribution and physiological function of adrenergic and muscarinic
receptor subtypes in the human heart. Basic research in cardiology,
96(6), 528-538.
Brown, S. J., Bryant, M., Mündel, T., & Stannard, S. (2012). Human cardiac
autonomic responses to head-up tilting during 72-h starvation.
European journal of applied physiology, 112(6), 2331-2339.
Brown, T. E., Beightol, L. A., Koh, J., & Eckberg, D. L. (1993). Important
influence of respiration on human R-R interval power spectra is largely
ignored. J Appl Physiol (1985), 75(5), 2310-2317. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/8307890
Bruno, C. M., Amaradio, M. D., Pricoco, G., Marino, E., & Bruno, F. (2018).
Lifestyle and hypertension: an evidence-based review. J Hypertens
Manag, 4(1), 1-10.
Burt, V. L., Whelton, P., Roccella, E. J., Brown, C., Cutler, J. A., Higgins, M., .
. . Labarthe, D. (1995). Prevalence of hypertension in the US adult
population. Results from the Third National Health and Nutrition
112

Examination Survey, 1988-1991. Hypertension, 25(3), 305-313.
Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/7875754
Cahill Jr, G. F. (1978). Physiology of acute starvation in man.
Callister, R., Suwarno, N. O., & Seals, D. R. (1992). Sympathetic activity is
influenced by task difficulty and stress perception during mental
challenge in humans. The Journal of Physiology, 454(1), 373-387.
doi:https://doi.org/10.1113/jphysiol.1992.sp019269
Cannon, W. B. (1922). Bodily changes in pain, hunger, fear and rage: An
account of recent researches into the function of emotional excitement:
D. Appleton.
Cannon, W. B. (1929). Organization for physiological homeostasis.
Physiological reviews, 9(3), 399-431.
Carroll, J. F., Kaiser, K. A., Franks, S. F., Deere, C., & Caffrey, J. L. (2007).
Influence of BMI and Gender on Postprandial Hormone Responses.
Obesity, 15(12), 2974-2983. doi:10.1038/oby.2007.355
Carter, J. R., Durocher, J. J., & Kern, R. P. (2008). Neural and cardiovascular
responses to emotional stress in humans. American Journal of
Physiology-Regulatory, Integrative and Comparative Physiology,
295(6), R1898-R1903. doi:10.1152/ajpregu.90646.2008
Carter, J. R., Fu, Q., Minson, C. T., & Joyner, M. J. (2013). Ovarian Cycle and
Sympathoexcitation in Premenopausal Women. Hypertension, 61(2),
395-399. doi:doi:10.1161/HYPERTENSIONAHA.112.202598
Carter, J. R., & Goldstein, D. S. (2015). Sympathoneural and
adrenomedullary responses to mental stress. Comprehensive
Physiology, 5(1), 119-146. doi:10.1002/cphy.c140030
Carter, J. R., Kupiers, N. T., & Ray, C. A. (2005). Neurovascular responses to
mental stress. The Journal of Physiology, 564(1), 321-327.
doi:10.1113/jphysiol.2004.079665
Carter, J. R., & Lawrence, J. E. (2007). Effects of the menstrual cycle on
sympathetic neural responses to mental stress in humans. The Journal
of Physiology, 585(Pt 2), 635-641. doi:10.1113/jphysiol.2007.141051
Carter, J. R., & Ray, C. A. (2009). Sympathetic neural responses to mental
stress: responders, nonresponders and sex differences. American
journal of physiology. Heart and circulatory physiology, 296(3), H847H853. doi:10.1152/ajpheart.01234.2008
Casolo, G. C., Stroder, P., Signorini, C., Calzolari, F., Zucchini, M., Balli, E., .
. . Lazzerini, S. (1992). Heart rate variability during the acute phase of
myocardial infarction. Circulation, 85(6), 2073-2079.
doi:doi:10.1161/01.CIR.85.6.2073
Casonatto, J., Goessler, K. F., Cornelissen, V. A., Cardoso, J. R., & Polito, M.
D. (2020). The blood pressure-lowering effect of a single bout of
resistance exercise: A systematic review and meta-analysis of
randomised controlled trials. European Journal of Preventive
Cardiology, 23(16), 1700-1714. doi:10.1177/2047487316664147
113

Chan, J. L., Mietus, J. E., Raciti, P. M., Goldberger, A. L., & Mantzoros, C. S.
(2007). Short-term fasting-induced autonomic activation and changes
in catecholamine levels are not mediated by changes in leptin levels in
healthy humans. Clinical Endocrinology, 66(1), 49-57.
doi:https://doi.org/10.1111/j.1365-2265.2006.02684.x
Chida, Y., & Steptoe, A. (2010). Greater Cardiovascular Responses to
Laboratory Mental Stress Are Associated With Poor Subsequent
Cardiovascular Risk Status. Hypertension, 55(4), 1026-1032.
doi:doi:10.1161/HYPERTENSIONAHA.109.146621
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A.,
Izzo Jr, J. L., . . . Wright Jr, J. T. (2003). Seventh report of the joint
national committee on prevention, detection, evaluation, and treatment
of high blood pressure. Hypertension, 42(6), 1206-1252.
Chon, T., Ma, A., & Mun-Price, C. (2017). Perioperative Fasting and the
Patient Experience. Cureus, 9(5), e1272. doi:10.7759/cureus.1272
Church, T. S., Thomas, D. M., Tudor-Locke, C., Katzmarzyk, P. T., Earnest,
C. P., Rodarte, R. Q., . . . Bouchard, C. (2011). Trends over 5 Decades
in U.S. Occupation-Related Physical Activity and Their Associations
with Obesity. PLOS ONE, 6(5), e19657.
doi:10.1371/journal.pone.0019657
Colman, R. J., Beasley, T. M., Kemnitz, J. W., Johnson, S. C., Weindruch, R.,
& Anderson, R. M. (2014). Caloric restriction reduces age-related and
all-cause mortality in rhesus monkeys. Nature communications, 5(1),
3557. doi:10.1038/ncomms4557
Cooke, W. H. (1998). Heart rate variability and baroreceptor responsiveness
to evaluate autonomic cardiovascular adaptations to exercise. Journal
of Exercise Physiology,
1(http://www.css.edu/users/tboone2/asep/jan13b.htm), 1-7.
Cooke, W. H., Cox, J. F., Diedrich, A. M., Taylor, J. A., Beightol, L. A., Ames,
J. E. t., . . . Eckberg, D. L. (1998). Controlled breathing protocols probe
human autonomic cardiovascular rhythms. Am J Physiol, 274(2 Pt 2),
H709-718. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/9486278
Cooke, W. H., Rickards, C. A., Ryan, K. L., Kuusela, T. A., & Convertino, V.
A. (2009). Muscle sympathetic nerve activity during intense lower body
negative pressure to presyncope in humans. The Journal of
Physiology, 587(20), 4987-4999. doi:10.1113/jphysiol.2009.177352
Cooke, W. H., Ryan, K. L., & Convertino, V. A. (2004). Lower body negative
pressure as a model to study progression to acute hemorrhagic shock
in humans. J Appl Physiol (1985), 96(4), 1249-1261.
doi:10.1152/japplphysiol.01155.2003
Cooke, W. H., Ryan, K. L., & Convertino, V. A. (2004). Lower body negative
pressure as a model to study progression to acute hemorrhagic shock
in humans. Journal of Applied Physiology, 96(4), 1249-1261.
114

Cooper, K., Edholm, O., & Mottram, R. (1955). The blood flow in skin and
muscle of the human forearm. The Journal of Physiology, 128(2), 258267.
Crittenden, A. N., & Schnorr, S. L. (2017). Current views on hunter‐gatherer
nutrition and the evolution of the human diet. American Journal of
Physical Anthropology, 162, 84-109.
DARLINGTON, D. N., NEVES, R. B., HA, T., CHEW, G., & DALLMAN, M. F.
(1990). Fed, but not Fasted, Adrenalectomized Rats Survive the Stress
of Hemorrhage and Hypovolemia*. Endocrinology, 127(2), 759-765.
doi:10.1210/endo-127-2-759
de Boer, R. W., Karemaker, J. M., & Strackee, J. (1985). Relationships
between short-term blood-pressure fluctuations and heart-rate
variability in resting subjects 1: a spectral analysis approach. Med.
Biol. Eng. Comput, 23, 352-358.
de Cabo, R., & Mattson, M. P. (2019). Effects of Intermittent Fasting on
Health, Aging, and Disease. New England Journal of Medicine,
381(26), 2541-2551. doi:10.1056/NEJMra1905136
Deanfield, J. E., Shea, M., Kensett, M., Horlock, P., Wilson, R. A., de
Landsheere, C. M., & Selwyn, A. P. (1984). Silent myocardial
ischaemia due to mental stress. Lancet, 2(8410), 1001-1005.
doi:10.1016/s0140-6736(84)91106-1
DeBeck, L. D., Petersen, S. R., Jones, K. E., & Stickland, M. K. (2010). Heart
rate variability and muscle sympathetic nerve activity response to
acute stress: the effect of breathing. American journal of physiology.
Regulatory, integrative and comparative physiology, 299(1), R80-R91.
doi:10.1152/ajpregu.00246.2009
deBoer, R. W., Karemaker, J. M., & Strackee, J. (1987). Hemodynamic
fluctuations and baroreflex sensitivity in humans: a beat-to-beat model.
American Journal of Physiology-Heart and Circulatory Physiology,
253(3), H680-H689. doi:10.1152/ajpheart.1987.253.3.H680
Dekker, J. M., Schouten, E. G., Klootwijk, P., Pool, J., Swenne, C. A., &
Kromhout, D. (1997). Heart Rate Variability from Short
Electrocardiographic Recordings Predicts Mortality from All Causes in
Middle-aged and Elderly Men: The Zutphen Study. American Journal
of Epidemiology, 145(10), 899-908.
doi:10.1093/oxfordjournals.aje.a009049
Diks, J., van Hoorn, D. E., Nijveldt, R. J., Boelens, P. G., Hofman, Z.,
Bouritius, H., . . . van Leeuwen, P. A. (2005). Preoperative fasting: an
outdated concept? JPEN J Parenter Enteral Nutr, 29(4), 298-304.
doi:10.1177/0148607105029004298
Dolan, E., Stanton, A., Thijs, L., Hinedi, K., Atkins, N., McClory, S., . . .
O’Brien, E. (2005). Superiority of Ambulatory Over Clinic Blood
Pressure Measurement in Predicting Mortality. Hypertension, 46(1),
156-161. doi:doi:10.1161/01.HYP.0000170138.56903.7a
115

Eckberg, D. L. (1997). Sympathovagal balance: a critical appraisal.
Circulation, 96, 3224-3232.
Einhorn, D., Young, J. B., & Landberg, L. (1982). Hypotensive effect of
fasting: possible involvement of the sympathetic nervous system and
endogenous opiates. Science, 217(4561), 727-729.
Electrophysiology, T. F. o. t. E. S. o. C. a. t. N. A. S. o. P. a. (1996). Heart
rate variability: Standards of measurement, physiological interpretation,
and clinical use. Circulation, 93, 1043-1065.
English, P. J., Ghatei, M. A., Malik, I. A., Bloom, S. R., & Wilding, J. P. H.
(2002). Food Fails to Suppress Ghrelin Levels in Obese Humans. The
Journal of Clinical Endocrinology & Metabolism, 87(6), 2984-2987.
doi:10.1210/jcem.87.6.8738
Epstein, A. E., Hirschowitz, B. I., Kirklin, J. K., Kirk, K. A., Nay, G. N., &
Plumb, V. J. (1990). Evidence for a central site of action to explain the
negative chronotropic effect of atropine: studies on the human
transplanted heart. Journal of the American College of Cardiology, 15,
1610-1617.
Espelund, U., Hansen, T. K., Hojlund, K., Beck-Nielsen, H., Clausen, J. T.,
Hansen, B. S., . . . Frystyk, J. (2005). Fasting unmasks a strong
inverse association between ghrelin and cortisol in serum: Studies in
obese and normal-weight subjects. Journal of Clinical Endocrinology &
Metabolism, 90(2), 741-746. doi:10.1210/jc.2004-0604
Fagius, J., & Wallin, B. G. (1993). Long-term variability and reproducibility of
resting human muscle nerve sympathetic activity at rest, as
reassessed after a decade. Clinical Autonomic Research, 3(3), 201205.
Farrell, T. G., Odemuyiwa, O., Bashir, Y., Cripps, T. R., Malik, M., & Ward, D.
E. (1992). Prognostic value of baroreflex sensitivity testing after acute
myocardial infarction. Br. Heart. J, 67, 129-137.
Finkelstein, E. A., Trogdon, J. G., Cohen, J. W., & Dietz, W. (2009). Annual
Medical Spending Attributable To Obesity: Payer-And Service-Specific
Estimates. Health Affairs, 28(Supplement 1), w822-w831.
doi:10.1377/hlthaff.28.5.w822
Fonkoue, I. T., & Carter, J. R. (2015). Sympathetic neural reactivity to mental
stress in humans: test-retest reproducibility. American journal of
physiology. Regulatory, integrative and comparative physiology,
309(11), R1380-R1386. doi:10.1152/ajpregu.00344.2015
Fontana, L., Meyer, T. E., Klein, S., & Holloszy, J. O. (2004). Long-term
calorie restriction is highly effective in reducing the risk for
atherosclerosis in humans. Proceedings of the National Academy of
Sciences, 101(17), 6659-6663.
Fontana, L., Partridge, L., & Longo, V. D. (2010). Extending healthy life
span—from yeast to humans. Science, 328(5976), 321-326.
116

Frankenfield, D., Roth-Yousey, L., & Compher, C. (2005). Comparison of
Predictive Equations for Resting Metabolic Rate in Healthy Nonobese
and Obese Adults: A Systematic Review. Journal of the American
Dietetic Association, 105(5), 775-789.
doi:https://doi.org/10.1016/j.jada.2005.02.005
Franklin, S. S., Khan, S. A., Wong, N. D., Larson, M. G., & Levy, D. (1999). Is
Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease?
Circulation, 100(4), 354-360. doi:doi:10.1161/01.CIR.100.4.354
Franklin, S. S., Thijs, L., Hansen, T. W., O’Brien, E., & Staessen, J. A. (2013).
White-Coat Hypertension. Hypertension, 62(6), 982-987.
doi:doi:10.1161/HYPERTENSIONAHA.113.01275
Glynn, L. G., Murphy, A. W., Smith, S. M., Schroeder, K., & Fahey, T. (2010).
Interventions used to improve control of blood pressure in patients with
hypertension. Cochrane Database Syst Rev(3), Cd005182.
doi:10.1002/14651858.CD005182.pub4
Gonzalez, J. E., & Cooke, W. H. (2021). Acute effects of electronic cigarettes
on arterial pressure and peripheral sympathetic activity in young
nonsmokers. American Journal of Physiology-Heart and Circulatory
Physiology, 320(1), H248-H255. doi:10.1152/ajpheart.00448.2020
Grassi, G., Bolla, G., Seravalle, G., Turri, C., Lanfranchi, A., & Mancia, G.
(1997). Comparison between reproducibility and sensitivity of muscle
sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci
(Lond), 92(3), 285-289. doi:10.1042/cs0920285
Grassi, G., Seravalle, G., Calhoun, D. A., Bolla, G. B., Giannattasio, C.,
Marabini, M., . . . Mancia, G. (1994). Mechanisms responsible for
sympathetic activation by cigarette smoking in humans. Circulation,
90(1), 248-253. doi:10.1161/01.cir.90.1.248
Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A.,
Colombo, M., . . . Mancia, G. (1995). Sympathetic activation in obese
normotensive subjects. Hypertension, 25(4 Pt 1), 560-563. Retrieved
from https://www.ncbi.nlm.nih.gov/pubmed/7721398
Grundler, F., Mesnage, R., Michalsen, A., & Toledo, F. W. d. (2020). Blood
Pressure Changes in 1610 Subjects With and Without
Antihypertensive Medication During Long&#x2010;Term Fasting.
journal of American Heart Association, 9(23), e018649.
doi:doi:10.1161/JAHA.120.018649
Guelen, I., Westerhof, B. E., van der Sar, G. L., van Montfrans, G. A.,
Kiemeneij, F., Wesseling, K. H., & Bos, W. J. (2008). Validation of
brachial artery pressure reconstruction from finger arterial pressure. J
Hypertens, 26(7), 1321-1327. doi:10.1097/HJH.0b013e3282fe1d28
Habito, R. C., & Ball, M. J. (2001). Postprandial changes in sex hormones
after meals of different composition. Metabolism-Clinical and
Experimental, 50(5), 505-511.
117

Hainsworth, R. (2004). Pathophysiology of syncope. Clinical Autonomic
Research, 14(1), i18-i24.
Hales, C. M., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2020). Prevalence
of Obesity and Severe Obesity Among Adults: United States, 20172018. NCHS Data Brief(360), 1-8. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/32487284
Hart, E. C., Charkoudian, N., Wallin, B. G., Curry, T. B., Eisenach, J., &
Joyner, M. J. (2011). Sex and ageing differences in resting arterial
pressure regulation: the role of the β-adrenergic receptors. The Journal
of Physiology, 589(21), 5285-5297.
doi:https://doi.org/10.1113/jphysiol.2011.212753
Hart, E. C., Charkoudian, N., Wallin, B. G., Curry, T. B., Eisenach, J. H., &
Joyner, M. J. (2009). Sex differences in sympathetic neuralhemodynamic balance: implications for human blood pressure
regulation. Hypertension, 53(3), 571-576.
Harvey, R. E., Hart, E. C., Charkoudian, N., Curry, T. B., Carter, J. R., Fu, Q.,
. . . Barnes, J. N. (2015). Oral Contraceptive Use, Muscle Sympathetic
Nerve Activity, and Systemic Hemodynamics in Young Women.
Hypertension, 66(3), 590-597.
doi:doi:10.1161/HYPERTENSIONAHA.115.05179
Hayano, J., Sakakibara, Y., Yamada, A., Yamada, M., Mukai, S., Fujinami, T.,
. . . Takata, K. (1991). Accuracy of assessment of cardiac vagal tone
by heart rate variability in normal subjects. Am. J. Cardiol, 67, 199-204.
Haymond, M. W., Karl, I. E., Clarke, W. L., Pagliara, A. S., & Santiago, J. V.
(1982). Differences in circulating gluconeogenic substrates during
short-term fasting in men, women, and children. Metabolism, 31(1), 3342.
Heilbronn, L. K., Smith, S. R., Martin, C. K., Anton, S. D., & Ravussin, E.
(2005). Alternate-day fasting in nonobese subjects: effects on body
weight, body composition, and energy metabolism. Am J Clin Nutr,
81(1), 69-73. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/15640462
Herbert, B. M., Herbert, C., Pollatos, O., Weimer, K., Enck, P., Sauer, H., &
Zipfel, S. (2012). Effects of short-term food deprivation on interoceptive
awareness, feelings and autonomic cardiac activity. Biol Psychol,
89(1), 71-79. doi:10.1016/j.biopsycho.2011.09.004
Hirsch, J. A., & Bishop, B. (1981). Respiratory sinus arrhythmia in humans:
how breathing pattern modulates heart rate. Am. J. Physiol, 241(10),
H620-H629.
Højlund, K., Wildner-Christensen, M., Eshøj, O., Skjærbæk, C., Holst, J. J.,
Koldkjær, O., . . . Beck-Nielsen, H. (2001). Reference intervals for
glucose, β-cell polypeptides, and counterregulatory factors during
prolonged fasting. American Journal of Physiology-Endocrinology and
Metabolism, 280(1), E50-E58. doi:10.1152/ajpendo.2001.280.1.E50
118

Høost, U., Kelbaek, H., Rasmusen, H., Court-Payen, M., Christensen, N. J.,
Pedersen-Bjergaard, U., & Lorenzen, T. (1996). Haemodynamic
effects of eating: the role of meal composition. Clin Sci (Lond), 90(4),
269-276. doi:10.1042/cs0900269
Horne, B. D., May, H. T., Anderson, J. L., Kfoury, A. G., Bailey, B. M.,
McClure, B. S., . . . Intermountain Heart Collaborative, S. (2008).
Usefulness of routine periodic fasting to lower risk of coronary artery
disease in patients undergoing coronary angiography. Am J Cardiol,
102(7), 814-819. doi:10.1016/j.amjcard.2008.05.021
Horne, B. D., Muhlestein, J. B., Lappe, D. L., May, H. T., Carlquist, J. F.,
Galenko, O., . . . Anderson, J. L. (2013). Randomized cross-over trial
of short-term water-only fasting: metabolic and cardiovascular
consequences. Nutr Metab Cardiovasc Dis, 23(11), 1050-1057.
doi:10.1016/j.numecd.2012.09.007
Horne, B. D., Muhlestein, J. B., May, H. T., Carlquist, J. F., Lappe, D. L., Bair,
T. L., . . . Intermountain Heart Collaborative Study, G. (2012). Relation
of routine, periodic fasting to risk of diabetes mellitus, and coronary
artery disease in patients undergoing coronary angiography. Am J
Cardiol, 109(11), 1558-1562. doi:10.1016/j.amjcard.2012.01.379
Imholz, B. P. M., Wieling, W., van Montfrans, G. A., & Wesseling, K. H.
(1998). Fifteen years experience with finger arterial pressure
monitoring: assessment of the technology. Cardiovasc. Res, 38, 605616.
Jansen, R. W., & Lipsitz, L. A. (1995). Postprandial hypotension:
epidemiology, pathophysiology, and clinical management. Annals of
internal medicine, 122(4), 286-295.
Jones, P. P., Davy, K. P., Alexander, S., & Seals, D. (1997). Age-related
increase in muscle sympathetic nerve activity is associated with
abdominal adiposity. American Journal of Physiology-Endocrinology
and Metabolism, 272(6), E976-E980.
Joyner, M. J., Charkoudian, N., & Wallin, B. G. (2010). Sympathetic Nervous
System and Blood Pressure in Humans. Hypertension, 56(1), 10-16.
doi:doi:10.1161/HYPERTENSIONAHA.109.140186
Joyner, M. J., Dietz, N. M., & Shepherd, J. T. (2001). From Belfast to Mayo
and beyond: the use and future of plethysmography to study blood flow
in human limbs. J Appl Physiol (1985), 91(6), 2431-2441.
doi:10.1152/jappl.2001.91.6.2431
Kannel, W. B., Gordon, T., & Schwartz, M. J. (1971). Systolic versus diastolic
blood pressure and risk of coronary heart disease: The Framingham
study. The American journal of cardiology, 27(4), 335-346.
doi:https://doi.org/10.1016/0002-9149(71)90428-0
Keir, D. A., Badrov, M. B., Tomlinson, G., Notarius, C. F., Kimmerly, D. S.,
Millar, P. J., . . . Floras, J. S. (2020). Influence of Sex and Age on
Muscle Sympathetic Nerve Activity of Healthy Normotensive Adults.
119

Hypertension, 76(3), 997-1005.
doi:doi:10.1161/HYPERTENSIONAHA.120.15208
Kimura, I., Inoue, D., Maeda, T., Hara, T., Ichimura, A., Miyauchi, S., . . .
Tsujimoto, G. (2011). Short-chain fatty acids and ketones directly
regulate sympathetic nervous system via G protein-coupled receptor
41 (GPR41). Proceedings of the National Academy of Sciences,
108(19), 8030. doi:10.1073/pnas.1016088108
Kirschbaum, C., Bono, E. G., Rohleder, N., Gessner, C., Pirke, K. M.,
Salvador, A., & Hellhammer, D. H. (1997). Effects of Fasting and
Glucose Load on Free Cortisol Responses to Stress and Nicotine*.
The Journal of Clinical Endocrinology & Metabolism, 82(4), 1101-1105.
doi:10.1210/jcem.82.4.3882
Krakoff, L. R. (2013). Ambulatory Blood Pressure Improves Prediction of
Cardiovascular Risk: Implications for Better Antihypertensive
Management. Current Atherosclerosis Reports, 15(4), 317.
doi:10.1007/s11883-013-0317-9
Kraus, W. E., Bhapkar, M., Huffman, K. M., Pieper, C. F., Das, S. K.,
Redman, L. M., . . . Ravussin, E. (2019). Two Years of Calorie
Restriction and Cardiometabolic Risk Factors. The lancet. Diabetes &
endocrinology, 7(9), 673.
Kück, J.-L., Bönhof, G. J., Strom, A., Zaharia, O.-P., Müssig, K., Szendroedi,
J., . . . Ziegler, D. (2020). Impairment in Baroreflex Sensitivity in
Recent-Onset Type 2 Diabetes Without Progression Over 5 Years.
Diabetes, 69(5), 1011-1019. doi:10.2337/db19-0990
Kuwahara, K., Okita, Y., Kouda, K., & Nakamura, H. (2011). Effects of
Modern Eating Patterns on the Cardiac Autonomic Nervous System in
Young Japanese Males. Journal of PHYSIOLOGICAL
ANTHROPOLOGY, 30(6), 223-231. doi:10.2114/jpa2.30.223
La Rovere, M. T., Bersano, C., Gnemmi, M., Specchia, G., & Schwartz, P. J.
(2002). Exercise-induced increase in baroreflex sensitivity predicts
improved prognosis after myocardial infarction. Circulation, 106(8),
945-949.
LANDSBERG, L. (1986). Diet, Obesity and Hypertension: An Hypothesis
Involving Insulin, the Sympathetic Nervous System, and Adaptive
Thermogenesis. QJM: An International Journal of Medicine, 61(3),
1081-1090. doi:10.1093/oxfordjournals.qjmed.a068066
Landsberg, L., & Young, J. B. (1978). Fasting, feeding and regulation of the
sympathetic nervous system. New England Journal of Medicine,
298(23), 1295-1301.
Langewouters, G., Wesseling, K., & Goedhard, W. (1984). The static elastic
properties of 45 human thoracic and 20 abdominal aortas in vitro and
the parameters of a new model. Journal of biomechanics, 17(6), 425435.
120

Ljungqvist, O., Jansson, E., & Ware, J. (1987). Effect of food deprivation on
survival after hemorrhage in the rat. Circ Shock, 22(3), 251-260.
Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/3621480
Lombardi, F., Sandrone, G., Spinnler, M. T., Torzillo, D., Lavezzaro, G. C.,
Brusca, A., & Malliani, A. (1996). Heart rate variability in the early
hours of an acute myocardial infarction. The American journal of
cardiology, 77(12), 1037-1044.
Mager, D. E., Wan, R., Brown, M., Cheng, A., Wareski, P., Abernethy, D. R.,
& Mattson, M. P. (2006). Caloric restriction and intermittent fasting alter
spectral measures of heart rate and blood pressure variability in rats.
The FASEB Journal, 20(6), 631-637. doi:https://doi.org/10.1096/fj.055263com
Malinowski, B., Zalewska, K., Węsierska, A., Sokołowska, M. M., Socha, M.,
Liczner, G., . . . Wiciński, M. (2019). Intermittent Fasting in
Cardiovascular Disorders-An Overview. Nutrients, 11(3), 673.
doi:10.3390/nu11030673
Malliani, A., Pagani, M., Lombardi, F., & Cerutti, S. (1991). Cardiovascular
neural regulation explored in the frequency domain. Circulation, 84,
482-492.
Mandsager, K., Harb, S., Cremer, P., Phelan, D., Nissen, S. E., & Jaber, W.
(2018). Association of Cardiorespiratory Fitness With Long-term
Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA
Network Open, 1(6), e183605-e183605.
doi:10.1001/jamanetworkopen.2018.3605
Manfrini, O., Pizzi, C., Trerè, D., Fontana, F., & Bugiardini, R. (2003).
Parasympathetic failure and risk of subsequent coronary events in
unstable angina and non-ST-segment elevation myocardial infarction.
European Heart Journal, 24(17), 1560-1566. doi:10.1016/s0195668x(03)00345-2
Mattison, J. A., Colman, R. J., Beasley, T. M., Allison, D. B., Kemnitz, J. W.,
Roth, G. S., . . . Anderson, R. M. (2017). Caloric restriction improves
health and survival of rhesus monkeys. Nature communications, 8(1),
1-12.
Mazurak, N., Gunther, A., Grau, F. S., Muth, E. R., Pustovoyt, M., Bischoff, S.
C., . . . Enck, P. (2013). Effects of a 48-h fast on heart rate variability
and cortisol levels in healthy female subjects. Eur J Clin Nutr, 67(4),
401-406. doi:10.1038/ejcn.2013.32
McCorry, L. K. (2007). Physiology of the autonomic nervous system.
American journal of pharmaceutical education, 71(4).
Merimee, T. J., Misbin, R. I., & Pulkkinen, A. J. (1978). Sex variations in free
fatty acids and ketones during fasting: evidence for a role of glucagon.
J Clin Endocrinol Metab, 46(3), 414-419. doi:10.1210/jcem-46-3-414
Minson, C. T., Halliwill, J. R., Young, T. M., & Joyner, M. J. (2000). Influence
of the Menstrual Cycle on Sympathetic Activity, Baroreflex Sensitivity,
121

and Vascular Transduction in Young Women. Circulation, 101(8), 862868. doi:doi:10.1161/01.CIR.101.8.862
Mitchell, G. F., Wang, N., Palmisano, J. N., Larson, M. G., Hamburg, N. M.,
Vita, J. A., . . . Vasan, R. S. (2010). Hemodynamic Correlates of Blood
Pressure Across the Adult Age Spectrum. Circulation, 122(14), 13791386. doi:doi:10.1161/CIRCULATIONAHA.109.914507
Monahan, K. D., Dinenno, F. A., Tanaka, H., Clevenger, C. M., DeSouza, C.
A., & Seals, D. R. (2000). Regular aerobic exercise modulates ageassociated declines in cardiovagal baroreflex sensitivity in healthy
men. The Journal of Physiology, 529 Pt 1(Pt 1), 263-271.
doi:10.1111/j.1469-7793.2000.00263.x
Moore, S. C., Patel, A. V., Matthews, C. E., de Gonzalez, A. B., Park, Y.,
Katki, H. A., . . . Helzlsouer, K. J. (2012). Leisure time physical activity
of moderate to vigorous intensity and mortality: a large pooled cohort
analysis. PLoS Med, 9(11), e1001335.
Moro, T., Tinsley, G., Bianco, A., Marcolin, G., Pacelli, Q. F., Battaglia, G., . . .
Paoli, A. (2016). Effects of eight weeks of time-restricted feeding (16/8)
on basal metabolism, maximal strength, body composition,
inflammation, and cardiovascular risk factors in resistance-trained
males. Journal of Translational Medicine, 14(1), 290.
doi:10.1186/s12967-016-1044-0
Mortara, A., La Rovere, M. T., Pinna, G. D., Prpa, A., Maestri, R., Febo, O., . .
. Tavazzi, L. (1997). Arterial baroreflex modulation of heart rate in
chronic heart failure: clinical and hemodynamic correlates and
prognostic implications. Circulation, 96(10), 3450-3458.
Muller, M. D., Sauder, C. L., & Ray, C. A. (2013). Mental stress elicits
sustained and reproducible increases in skin sympathetic nerve
activity. Physiological reports, 1(1).
Narkiewicz, K., Phillips, B. G., Kato, M., Hering, D., Bieniaszewski, L., &
Somers, V. K. (2005). Gender-Selective Interaction Between Aging,
Blood Pressure, and Sympathetic Nerve Activity. Hypertension, 45(4),
522-525. doi:doi:10.1161/01.HYP.0000160318.46725.46
Natalucci, G., Riedl, S., Gleiss, A., Zidek, T., & Frisch, H. (2005).
Spontaneous 24-h ghrelin secretion pattern in fasting subjects:
maintenance of a meal-related pattern. Eur J Endocrinol, 152(6), 845850. doi:10.1530/eje.1.01919
Nunan, D., Sandercock, G. R., & Brodie, D. A. (2010). A quantitative
systematic review of normal values for short‐term heart rate variability
in healthy adults. Pacing and clinical electrophysiology, 33(11), 14071417.
O'Dea, K., Esler, M., Leonard, P., Stockigt, J., & Nestel, P. (1982).
Noradrenaline turnover during under-and over-eating in normal weight
subjects. Metabolism, 31(9), 896-899.
122

O’Brien, E., Parati, G., & Stergiou, G. (2013). Ambulatory Blood Pressure
Measurement. Hypertension, 62(6), 988-994.
doi:doi:10.1161/HYPERTENSIONAHA.113.02148
Ogden, C. L., Fakhouri, T. H., Carroll, M. D., Hales, C. M., Fryar, C. D., Li, X.,
& Freedman, D. S. (2017). Prevalence of Obesity Among Adults, by
Household Income and Education - United States, 2011-2014. MMWR
Morb Mortal Wkly Rep, 66(50), 1369-1373.
doi:10.15585/mmwr.mm6650a1
Ohara, K., Okita, Y., Kouda, K., Mase, T., Miyawaki, C., & Nakamura, H.
(2015). Cardiovascular response to short-term fasting in menstrual
phases in young women: an observational study. BMC women's
health, 15, 67-67. doi:10.1186/s12905-015-0224-z
Pagani, M., Montano, N., Porta, A., Malliani, A., Abboud, F. M., Birkett, C., &
Somers, V. K. (1997). Relationship Between Spectral Components of
Cardiovascular Variabilities and Direct Measures of Muscle
Sympathetic Nerve Activity in Humans. Circulation, 95(6), 1441-1448.
doi:doi:10.1161/01.CIR.95.6.1441
Palamarchuk, I., Ives, C. T., Hachinski, V., & Kimpinski, K. (2014). Baroreflex
sensitivity: reliability of baroreflex components of the Valsalva
maneuver. Auton Neurosci, 185, 138-140.
doi:10.1016/j.autneu.2014.05.002
Parlow, J., Viale, J.-P., Annat, G., Hughson, R., & Quintin, L. (1995).
Spontaneous cardiac baroreflex in humans. Comparison with druginduced responses. Hypertension, 25, 1058-1068.
Patel, J. N., Eisenhofer, G., Coppack, S. W., & Miles, J. M. (1999).
Norepinephrine spillover in forearm and subcutaneous adipose tissue
before and after eating. J Clin Endocrinol Metab, 84(8), 2815-2819.
doi:10.1210/jcem.84.8.5882
Peeters, A., Barendregt, J. J., Willekens, F., Mackenbach, J. P., Mamun, A.
A., & Bonneux, L. (2003). Obesity in Adulthood and Its Consequences
for Life Expectancy: A Life-Table Analysis. Annals of internal medicine,
138(1), 24-32. doi:10.7326/0003-4819-138-1-200301070-00008
Penev, P., Spiegel, K., Marcinkowski, T., & Van Cauter, E. (2005). Impact of
Carbohydrate-Rich Meals on Plasma Epinephrine Levels:
Dysregulation with Aging. The Journal of Clinical Endocrinology &
Metabolism, 90(11), 6198-6206. doi:10.1210/jc.2005-0415
Piccirillo, G., Munizzi, M. R., Fimognari, F. L., & Marigliano, V. (1996). Heart
rate variability in hypertensive subjects. International Journal of
Cardiology, 53(3), 291-298.
Pitzalis, M. V., Mastropasqua, F., Massari, F., Forleo, C., Di Maggio, M.,
Passantino, A., . . . Rizzon, P. (1996). Short- and long-term
reproducibility of time and frequency domain heart rate variability
measurements in normal subjects. Cardiovascular Research, 32(2),
226-233. doi:10.1016/0008-6363(96)00086-7
123

Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., . .
. Metabolism. (2006). Obesity and cardiovascular disease:
pathophysiology, evaluation, and effect of weight loss: an update of the
1997 American Heart Association Scientific Statement on Obesity and
Heart Disease from the Obesity Committee of the Council on Nutrition,
Physical Activity, and Metabolism. Circulation, 113(6), 898-918.
doi:10.1161/CIRCULATIONAHA.106.171016
Pomeranz, B., Macaulay, R. J. B., Caudill, M. A., Kutz, I., Adam, D., Gordon,
D., . . . Benson, H. (1985). Assessment of autonomic function in
humans by heart rate spectral analysis. Am. J. Physiol, 248, H151H153.
Pontet, J., Contreras, P., Curbelo, A., Medina, J., Noveri, S., Bentancourt, S.,
& Migliaro, E. R. (2003). Heart rate variability as early marker of
multiple organ dysfunction syndrome in septic patients. Journal of
Critical Care, 18(3), 156-163.
doi:https://doi.org/10.1016/j.jcrc.2003.08.005
Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic
Agents to Reduce the Risk of Pulmonary Aspiration: Application to
Healthy Patients Undergoing Elective Procedures: An Updated Report
by the American Society of Anesthesiologists Task Force on
Preoperative Fasting and the Use of Pharmacologic Agents to Reduce
the Risk of Pulmonary Aspiration*. (2017). Anesthesiology, 126(3),
376-393. doi:10.1097/aln.0000000000001452
Prentice, A. M., & Jebb, S. A. (2003). Fast foods, energy density and obesity:
a possible mechanistic link. Obesity Reviews, 4(4), 187-194.
doi:https://doi.org/10.1046/j.1467-789X.2003.00117.x
Ray, C. A., & Carter, J. R. (2010). Effects of aerobic exercise training on
sympathetic and renal responses to mental stress in humans. Am J
Physiol Heart Circ Physiol, 298(1), H229-234.
doi:10.1152/ajpheart.00880.2009
Reid, C., Nelson, M. R., Shiel, L., Chew, D., Connor, G., & DeLooze, F.
(2008). Australians at Risk: Management of Cardiovascular Risk
Factors in the REACH Registry. Heart, Lung and Circulation, 17(2),
114-118. doi:https://doi.org/10.1016/j.hlc.2007.07.009
Reimers, C. D., Knapp, G., & Reimers, A. K. (2012). Does physical activity
increase life expectancy? A review of the literature. Journal of aging
research, 2012, 243958-243958. doi:10.1155/2012/243958
Robertson, D., Wade, D., & Robertson, R. M. (1981). Postprandial alterations
in cardiovascular hemodynamics in autonomic dysfunction states. Am
J Cardiol, 48(6), 1048-1052. doi:10.1016/0002-9149(81)90319-2
Rocchini, A. P., Moorehead, C. P., DeRemer, S., & Bondie, D. (1989).
Pathogenesis of weight-related changes in blood pressure in dogs.
Hypertension, 13(6_pt_2), 922-928. doi:doi:10.1161/01.HYP.13.6.922
124

Rodrigues, J. A. L., Yamane, A. C., Gonçalves, T. C. P., Kalva-Filho, C.,
Papoti, M., & Júnior, C. R. B. (2019). Fed and fasted states on heart
rate variability, hemodynamic heart rate and blood pressure in adults
submitted to moderate aerobic exercise. IJC Heart & Vasculature, 23,
100378. doi:https://doi.org/10.1016/j.ijcha.2019.100378
Rovere, M. T. L., Pinna, G. D., Hohnloser, S. H., Marcus, F. I., Mortara, A.,
Nohara, R., . . . Schwartz, P. J. (2001). Baroreflex Sensitivity and Heart
Rate Variability in the Identification of Patients at Risk for LifeThreatening Arrhythmias. Circulation, 103(16), 2072-2077.
doi:doi:10.1161/01.CIR.103.16.2072
Rovere, M. T. L., Pinna, G. D., Maestri, R., Mortara, A., Capomolla, S., Febo,
O., . . . Cobelli, F. (2003). Short-Term Heart Rate Variability Strongly
Predicts Sudden Cardiac Death in Chronic Heart Failure Patients.
Circulation, 107(4), 565-570.
doi:doi:10.1161/01.CIR.0000047275.25795.17
Rowell, L. B. (1993). Human cardiovascular control: Oxford University Press,
USA.
Samad, F., Qazi, F., Pervaiz, M. B., Kella, D. K., Mansoor, M., Osmani, B. Z.,
. . . Kadir, M. M. (2015). EFFECTS OF RAMADAN FASTING ON
BLOOD PRESSURE IN NORMOTENSIVE MALES. Journal of Ayub
Medical College, Abbottabad : JAMC, 27(2), 338-342. Retrieved from
http://europepmc.org/abstract/MED/26411111
Sanders, J. S., Ferguson, D. W., & Mark, A. L. (1988). Arterial baroreflex
control of sympathetic nerve activity during elevation of blood pressure
in normal man: dominance of aortic baroreflexes. Circulation, 77(2),
279-288.
Shaffer, F., McCraty, R., & Zerr, C. L. (2014). A healthy heart is not a
metronome: an integrative review of the heart's anatomy and heart rate
variability. Frontiers in Psychology, 5(1040).
doi:10.3389/fpsyg.2014.01040
Shykoff, B. E., Naqvi, S. S., Menon, A. S., & Slutsky, A. S. (1991).
Respiratory sinus arrhythmia in dogs. Effects of phasic afferents and
chemostimulation. The Journal of Clinical Investigation, 87(5), 16211627. doi:10.1172/JCI115176
Sidery, M. B., Macdonald, I. A., Cowley, A. J., & Fullwood, L. J. (1991).
Cardiovascular responses to high-fat and high-carbohydrate meals in
young subjects. Am J Physiol, 261(5 Pt 2), H1430-1436.
doi:10.1152/ajpheart.1991.261.5.H1430
Silva, L. E. V., Dias, D. P. M., da Silva, C. A. A., Salgado, H. C., & Fazan, R.,
Jr. (2019). Revisiting the Sequence Method for Baroreflex Analysis.
Frontiers in neuroscience, 13, 17-17. doi:10.3389/fnins.2019.00017
Skarphedinsson, J. O., Elam, M., Jungersten, L., & Wallin, B. G. (1997).
Sympathetic nerve traffic correlates with the release of nitric oxide in
humans: implications for blood pressure control. The Journal of
125

Physiology, 501(3), 671-675. doi:https://doi.org/10.1111/j.14697793.1997.671bm.x
Solianik, R., Sujeta, A., Terentjeviene, A., & Skurvydas, A. (2016). Effect of
48 h Fasting on Autonomic Function, Brain Activity, Cognition, and
Mood in Amateur Weight Lifters. Biomed Res Int, 2016, 1503956.
doi:10.1155/2016/1503956
Someya, N., Endo, M. Y., Fukuba, Y., Hirooka, Y., & Hayashi, N. (2010).
Effects of a mental task on splanchnic blood flow in fasting and
postprandial conditions. European journal of applied physiology,
108(6), 1107-1113.
Spence, J., LeManach, Y., Chan, M. T. V., Wang, C. Y., Sigamani, A., Xavier,
D., . . . Devereaux, P. J. (2019). Association between complications
and death within 30 days after noncardiac surgery. Canadian Medical
Association Journal, 191(30), E830. doi:10.1503/cmaj.190221
Stekovic, S., Hofer, S. J., Tripolt, N., Aon, M. A., Royer, P., Pein, L., . . . Url, J.
(2019). Alternate day fasting improves physiological and molecular
markers of aging in healthy, non-obese humans. Cell metabolism,
30(3), 462-476. e466.
Stimson, R. H., Mohd-Shukri, N. A., Bolton, J. L., Andrew, R., Reynolds, R.
M., & Walker, B. R. (2014). The Postprandial Rise in Plasma Cortisol in
Men Is Mediated by Macronutrient-Specific Stimulation of Adrenal and
Extra-Adrenal Cortisol Production. The Journal of Clinical
Endocrinology & Metabolism, 99(1), 160-168. doi:10.1210/jc.20132307
Sundlof, G., & Wallin, B. G. (1977). The variability of muscle nerve
sympathetic activity in resting recumbent man. J. Physiol, 272, 383397.
Sundlof, G., & Wallin, B. G. (1978). Human muscle nerve sympathetic activity
at rest. Relationship to blood pressure and age. J. Physiol, 274, 621637.
Tonacio, A., Trombetta, I., Rondon, M., Batalha, L., Kuniyoshi, F., Laterza,
M., . . . Halpern, A. (2006). Effects of diet and exercise training on
neurovascular control during mental stress in obese women. Brazilian
Journal of Medical and Biological Research, 39, 53-62.
Torres, S. J., & Nowson, C. A. (2007). Effect of a weight-loss program on
mental stress–induced cardiovascular responses and recovery.
Nutrition, 23(7), 521-528. doi:https://doi.org/10.1016/j.nut.2007.04.016
Truijen, J., van Lieshout, J. J., Wesselink, W. A., & Westerhof, B. E. (2012).
Noninvasive continuous hemodynamic monitoring. Journal of clinical
monitoring and computing, 26(4), 267-278. doi:10.1007/s10877-0129375-8
Vallbo, Å. B., Hagbarth, K.-E., & Wallin, B. G. (2004). Microneurography: how
the technique developed and its role in the investigation of the
126

sympathetic nervous system. Journal of Applied Physiology, 96(4),
1262-1269. doi:10.1152/japplphysiol.00470.2003
van Baak, M. A. (2008). Meal-induced activation of the sympathetic nervous
system and its cardiovascular and thermogenic effects in man. Physiol
Behav, 94(2), 178-186. doi:10.1016/j.physbeh.2007.12.020
van Wijnen, V. K., Finucane, C., Harms, M. P. M., Nolan, H., Freeman, R. L.,
Westerhof, B. E., . . . Wieling, W. (2017). Noninvasive beat-to-beat
finger arterial pressure monitoring during orthostasis: a comprehensive
review of normal and abnormal responses at different ages. Journal of
Internal Medicine, 282(6), 468-483.
doi:https://doi.org/10.1111/joim.12636
Varady, K. A., Bhutani, S., Klempel, M. C., Kroeger, C. M., Trepanowski, J.
F., Haus, J. M., . . . Calvo, Y. (2013). Alternate day fasting for weight
loss in normal weight and overweight subjects: a randomized
controlled trial. Nutrition journal, 12(1), 146.
Varady, K. A., & Hellerstein, M. K. (2007). Alternate-day fasting and chronic
disease prevention: a review of human and animal trials. The American
Journal of Clinical Nutrition, 86(1), 7-13. doi:10.1093/ajcn/86.1.7
Vaz, M., Jennings, G., Turner, A., Cox, H., Lambert, G., & Esler, M. (1997).
Regional Sympathetic Nervous Activity and Oxygen Consumption in
Obese Normotensive Human Subjects. Circulation, 96(10), 3423-3429.
doi:doi:10.1161/01.CIR.96.10.3423
Wallin, B., Thompson, J., Jennings, G., & Esler, M. (1996). Renal
noradrenaline spillover correlates with muscle sympathetic activity in
humans. The Journal of Physiology, 491(3), 881-887.
Wallin, B. G., Esler, M., Dorward, P., Eisenhofer, G., Rerrier, C., Westerman,
R., & Jennings, G. (1992). Simultaneous measurements of cardiac
noradrenaline spillover and sympathetic outflow to skeletal muscle in
humans. J. Physiol, 453, 45-58.
Wallin, B. G., Kunimoto, M. M., & Sellgren, J. (1993). Possible genetic
influence on the strength of human muscle nerve sympathetic activity
at rest. Hypertension, 22(3), 282-284.
doi:doi:10.1161/01.HYP.22.3.282
Wallin, B. G., Sundlöf, G., & Delius, W. (1975). The effect of carotid sinus
nerve stimulation on muscle and skin nerve sympathetic activity in
man. Pflugers Arch, 358(2), 101-110. doi:10.1007/bf00583921
Waseem, T., Mogensen, K. M., Lautz, D. B., & Robinson, M. K. (2007).
Pathophysiology of Obesity: Why Surgery Remains the Most Effective
Treatment. Obesity Surgery, 17(10), 1389. doi:10.1007/s11695-0079220-1
Watkins, E., & Serpell, L. (2016). The Psychological Effects of Short-Term
Fasting in Healthy Women. Frontiers in nutrition, 3, 27-27.
doi:10.3389/fnut.2016.00027
127

Webber, J., & Macdonald, I. A. (1994). The cardiovascular, metabolic and
hormonal changes accompanying acute starvation in men and women.
British Journal of Nutrition, 71(3), 437-447. doi:10.1079/BJN19940150
Webber, J., Taylor, J., Greathead, H., Dawson, J., Buttery, P., & Macdonald,
I. (1995). The effects of fasting on the thermogenic, metabolic and
cardiovascular responses to infused adrenaline. British Journal of
Nutrition, 74(4), 477-490.
Wehrwein, E. A., Orer, H. S., & Barman, S. M. (2011). Overview of the
anatomy, physiology, and pharmacology of the autonomic nervous
system. Comprehensive Physiology, 6(3), 1239-1278.
Westerveld, H. (1998). Estrogens and postprandial lipid metabolism.
Atherosclerosis, 141, S105-S107.
Whitney, R. (1953). The measurement of volume changes in human limbs.
The Journal of Physiology, 121(1), 1-27.
Wiinberg, N., Høegholm, A., Christensen, H. R., Bang, L. E., Mikkelsen, K. L.,
Nielsen, P. E., . . . Bentzon, M. W. (1995). 24-h ambulatory blood
pressure in 352 normal Danish subjects, related to age and gender.
American journal of hypertension, 8(10), 978-986.
William Tank, A., & Lee Wong, D. (2011). Peripheral and central effects of
circulating catecholamines. Comprehensive Physiology, 5(1), 1-15.
Wilson, P. W. (1997). An epidemiologic perspective of systemic hypertension,
ischemic heart disease, and heart failure. The American journal of
cardiology, 80(9), 3J-8J.
Wright, J. D., Kennedy-Stephenson, J., Wang, C.-Y., McDowell, M., &
Johnson, C. L. (2004). Trends in intake of energy and macronutrientsUnited States, 1971-2000. MMWR: Morbidity & Mortality Weekly
Report, 53(4), 80-80.
Yamazaki, F., Yamauchi, K., Tsutsui, Y., Endo, Y., Sagawa, S., & Shiraki, K.
(2003). Whole body heating reduces the baroreflex response of
sympathetic nerve activity during Valsalva straining. Auton Neurosci,
103(1-2), 93-99. doi:10.1016/s1566-0702(02)00140-6
Yan, L. L., Liu, K., Matthews, K. A., Daviglus, M. L., Ferguson, T. F., & Kiefe,
C. I. (2003). Psychosocial factors and risk of hypertension: the
Coronary Artery Risk Development in Young Adults (CARDIA) study.
JAMA, 290(16), 2138-2148. doi:10.1001/jama.290.16.2138
Yang, H., Durocher, J. J., Larson, R. A., Dellavalla, J. P., & Carter, J. R.
(2012). Total sleep deprivation alters cardiovascular reactivity to acute
stressors in humans. Journal of applied physiology (Bethesda, Md. :
1985), 113(6), 903-908. doi:10.1152/japplphysiol.00561.2012
Yates, B. J., Bolton, P. S., & Macefield, V. G. (2014). Vestibulo-sympathetic
responses. Comprehensive Physiology, 4(2), 851-887.
doi:10.1002/cphy.c130041
Young, C. N., Deo, S. H., Chaudhary, K., Thyfault, J. P., & Fadel, P. J.
(2010). Insulin enhances the gain of arterial baroreflex control of
128

muscle sympathetic nerve activity in humans. J Physiol, 588(Pt 18),
3593-3603. doi:10.1113/jphysiol.2010.191866
Young, J. B., & Landsberg, L. (1977). Suppression of sympathetic nervous
system during fasting. Science, 196(4297), 1473-1475.
Young, J. B., Rosa, R. M., & Landsberg, L. (1984). Dissociation of
sympathetic nervous system and adrenal medullary responses.
American Journal of Physiology-Endocrinology and Metabolism,
247(1), E35-E40. doi:10.1152/ajpendo.1984.247.1.E35
Zouhal, H., Jacob, C., Delamarche, P., & Gratas-Delamarche, A. (2008).
Catecholamines and the effects of exercise, training and gender.
Sports medicine, 38(5), 401-423.

129

A APPENDICES
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Example Subject Information Sheet
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A.2

Calories to Points Calculation Example
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A.3

Subway Lunch
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A.4

LBNP Normalization Procedure
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